Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Prof. Dr. med. Jan Dürig

Telefax
duerig@t-online

Funktionen

  • ---, Zentrum für Innere Medizin

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Kriegsmann, Katharina; Ton, Gigi Nu Hoang Quy; Awwad, Mohamed H. S.; Benner, Axel; Bertsch, Uta; Besemer, Britta; Hänel, Mathias; Fenk, Roland; Munder, Markus; Dürig, Jan; Blau, Igor W.; Huhn, Stefanie; Hose, Dirk; Jauch, Anna; Mann, Christoph; Weinhold, Niels; Scheid, Christof; Schroers, Roland; von Metzler, Ivana; Schieferdecker, Aneta; Thomalla, Jörg; Reimer, Peter; Mahlberg, Rolf; Graeven, Ullrich; Kremers, Stephan; Martens, Uwe M.; Kunz, Christian; Hensel, Manfred; Seidel-Glätzer, Andrea; Weisel, Katja C.; Salwender, Hans J.; Müller-Tidow, Carsten; Raab, Marc S.; Goldschmidt, Hartmut; Mai, Elias K.; Hundemer, Michael
    CD8⁺ CD28⁻ regulatory T cells after induction therapy predict progression-free survival in myeloma patients : Results from the GMMG-HD6 multicenter phase III study
    In: Leukemia Jg. 38 (2024) Nr. 7, S. 1621 - 1625
    Online Volltext: dx.doi.org/ (Open Access)
  • Mai, Elias K; Goldschmid, Hartmut; Miah, Kaya; Bertsch, Uta; Besemer, Britta; Hänel, Mathias; Krzykalla, Julia; Fenk, Roland; Schlenzka, Jana; Munder, Markus; Dürig, Jan; Blau, Igor W; Huhn, Stefanie; Hose, Dirk; Jauch, Anna; Kunz, Christina; Mann, Christoph; Weinhold, Niels; Scheid, Christof; Schroers, Roland; von Metzler, Ivana; Schieferdecker, Aneta; Thomalla, Jörg; Reimer, Peter; Mahlberg, Rolf; Graeven, Ullrich; Kremers, Stephan; Martens, Uwe M; Kunz, Christian; Hensel, Manfred; Benner, Axel; Seidel-Glätzer, Andrea; Weisel, Katja C; Raab, Marc S; Salwender, Hans J; Adrian, Nicole; Bernhard, Helga; Böck, Hans-Peter; Bolling, Claus; Dingeldein, Gerrit; Emde, Till-Oliver; Ferstl, Barbara; Fietz, Thomas; Fronhoffs, Stefan; Fuhrmann, Stephan; Fuxius, Stefan; Geer, Thomas; Görner, Martin; Guenther, Barbara; Hartmann, Frank; Heilmeier, Bernhard; Heinsch, Michael; Hoffmann, Martin; Holderried, Tobias A.W.; Klein, Stefan; Klump, Martin; Knauf, Wolfgang; La Rosée, Paul; Lange, Elisabeth; Lindemann, Walter; Lopez, Roderico; Mayer, Frank; Nückel, Holger; Papesch, Eva; Procaccianti, Maria; Reichart, Alexander; Rummel, Mathias; Scheuer, Lars; Schmitt, Hans-Roland; Staib, Peter; Steiniger, Heike; Tischler, Hans-Joachim; Ulshöfer, Thomas; Verbeek, Walter; Wacker, Alexander; Zirpel, Iris; Goldschmidt, Hartmut
    Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial
    In: The Lancet Haematology Jg. 11 (2024) Nr. 2, S. e101 - e113
    Online Volltext: dx.doi.org/ (Open Access)
  • Fürstenau, Moritz; Kater, Arnon P; Robrecht, Sandra; von Tresckow, Julia; Zhang, Can; Gregor, Michael; Thornton, Patrick; Staber, Philipp B; Tadmor, Tamar; Lindström, Vesa; Juliusson, Gunnar; Janssens, Ann; Levin, Mark-David; da Cunha-Bang, Caspar; Schneider, Christof; Goldschmidt, Neta; Vandenberghe, Elisabeth; Rossi, Davide; Benz, Rudolf; Nösslinger, Thomas; Heintel, Daniel; Poulsen, Christian B; Christiansen, Ilse; Frederiksen, Henrik; Enggaard, Lisbeth; Posthuma, Eduardus F M; Issa, Djamila E; Visser, Hein P J; Bellido, Mar; Kutsch, Nadine; Dürig, Jan; Stehle, Alexander; Vöhringer, Matthias; Böttcher, Sebastian; Schulte, Clemens; Simon, Florian; Fink, Anna-Maria; Fischer, Kirsten; Holmes, Emily E; Kreuzer, Karl-Anton; Ritgen, Matthias; Brüggemann, Monika; Tausch, Eugen; Stilgenbauer, Stephan; Hallek, Michael; Niemann, Carsten U; Eichhorst, Barbara
    First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13) : 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
    In: The Lancet Oncology Jg. 25 (2024) Nr. 6, S. 744 - 759
    Online Volltext: dx.doi.org/ (Open Access)
  • Mai, Elias K.; Hielscher, Thomas; Bertsch, Uta; Salwender, Hans J.; Zweegman, Sonja; Raab, Marc S.; Munder, Markus; Pantani, Lucia; Mancuso, Katia; Brossart, Peter; Beksac, Meral; Blau, Igor W.; Dürig, Jan; Besemer, Britta; Fenk, Roland; Reimer, Peter; van der Holt, Bronno; Hänel, Mathias; von Metzler, Ivana; Graeven, Ullrich; Müller-Tidow, Carsten; Boccadoro, Mario; Scheid, Christof; Dimopoulos, Meletios A.; Hillengass, Jens; Weisel, Katja C.; Cavo, Michele; Sonneveld, Pieter; Goldschmidt, Hartmut
    Predictors of early morbidity and mortality in newly diagnosed multiple myeloma : Data from five randomized, controlled, phase III trials in 3700 patients
    In: Leukemia Jg. 38 (2024) Nr. 3, S. 640 - 647
    Online Volltext: dx.doi.org/ (Open Access)
  • Kriegsmann, Katharina; Manta, Calin; Schwab, Ricarda; Mai, Elias K.; Raab, Marc S.; Salwender, Hans J.; Fenk, Roland; Besemer, Britta; Dürig, Jan; Schroers, Roland; von Metzler, Ivana; Hänel, Mathias; Mann, Christoph; Asemissen, Anne M.; Heilmeier, Bernhard; Bertsch, Uta; Huhn, Stefanie; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hundemer, Michael
    Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM
    In: Blood Advances Jg. 7 (2023) Nr. 3, S. 379 - 383
    Online Volltext: dx.doi.org/ (Open Access)
  • Huber, Henriette; Tausch, Eugen; Schneider, Christof; Edenhofer, Simone; von Tresckow, Julia; Robrecht, Sandra; Giza, Adam; Zhang, Can; Fürstenau, Moritz; Dreger, Peter; Ritgen, Matthias; Illmer, Thomas; Illert, Anna Lena; Dürig, Jan; Böttcher, Sebastian; Niemann, Carsten U.; Kneba, Michael; Al-Sawaf, Othman; Kreuzer, Karl-Anton; Fink, Anna-Maria; Fischer, Kirsten; Döhner, Hartmut; Hallek, Michael; Eichhorst, Barbara; Stilgenbauer, Stephan
    Final analysis of the CLL2-GIVe trial : obinutuzumab, ibrutinib and venetoclax in untreated CLL with del(17p)/TP53mut
    In: Blood Jg. 142 (2023) Nr. 11, S. 961 - 972
    Online Volltext: dx.doi.org/
  • Hermine, Olivier; Jiang, Linmiao; Walewski, Jan; Bosly, André; Thieblemont, Catherine; Szymczyk, Michal; Pott, Christiane; Salles, Gilles; Feugier, Pierre; Hübel, Kai; Haioun, Corinne; Casasnovas, René Olivier; Schmidt, Christian; Bouabdallah, Kamal; Ribrag, Vincent; Kanz, Lothar; Dürig, Jan; Metzner, Bernd; Sibon, David; Cheminant, Morgane; Burroni, Barbara; Klapper, Wolfram; Hiddemann, Wolfgang; Unterhalt, Michael; Hoster, Eva; Dreyling, Martin
    High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma : Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
    In: Journal of Clinical Oncology (JCO) Jg. 41 (2023) Nr. 3, S. 479 - 484
    Online Volltext: dx.doi.org/
  • Johansson, Patricia; Alig, Stefan; Richter, Julia; Hanoun, Christine; Rekowski, Jan; Dürig, Jan; Ylstra, Bauke; de Jong, Daphne; Klapper, Wolfram; Alizadeh, Ash A.; Dührsen, Ulrich; Hüttmann, Andreas
    Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma
    In: Annals of Hematology Jg. 102 (2023) Nr. 12, S. 3445 - 3455
    Online Volltext: dx.doi.org/ (Open Access)
  • Johansson, Patricia; Laguna, Teresa; Ossowski, Julio; Pancaldi, Vera; Brauser, Martina; Dührsen, Ulrich; Keuneke, Lara; Queiros, Ana; Richter, Julia; Martín-Subero, José I.; Siebert, Reiner; Schlegelberger, Brigitte; Küppers, Ralf; Dürig, Jan; Penas, Eva M. Murga; Pau, Enrique Carrillo-de Santa; Bergmann, Anke K.
    Publisher Correction: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
    In: Clinical Epigenetics Jg. 15 (2023) Nr. 1, 3
    Online Volltext: dx.doi.org/ (Open Access)
  • Baak, Lisa; Frank, Mirjam; Dürig, Jan; Dührsen, Ulrich; Hoffmann, Per; Nöthen, Markus M.; Dragano, Nico; Erbel, Raimund; Jöckel, Karl-Heinz; Schmidt, Börge
    A genetic risk score of alleles related to MGUS interacts with socioeconomic position in a population-based cohort
    In: Scientific Reports Jg. 12 (2022) Nr. 1, 4409
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Goldschmidt, Hartmut; Mai, Elias K.; Bertsch, Uta; Fenk, Roland; Nievergall, Eva; Tichy, Diana; Besemer, Britta; Dürig, Jan; Schroers, Roland; von Metzler, Ivana; Hänel, Mathias; Mann, Christoph; Asemissen, Anne M.; Heilmeier, Bernhard; Weinhold, Niels; Huhn, Stefanie; Kriegsmann, Katharina; Luntz, Steffen P.; Holderried, Tobias A W; Trautmann-Grill, Karolin; Gezer, Deniz; Klaiber-Hakimi, Maika; Müller, Martin; Khandanpour, Cyrus; Knauf, Wolfgang; Scheid, Christof; Munder, Markus; Geer, Thomas; Riesenberg, Hendrik; Thomalla, Jörg; Hoffmann, Martin; Raab, Marc S.; Salwender, Hans J.; Weisel, Katja C.; Ziske, Carsten; Nückel, Holger; Steiniger, Heike;
    German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators (Hrsg.)
    Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7) : Part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
    In: The Lancet Haematology Jg. 9 (2022) Nr. 11, S. e810 - e821
    Online Volltext: dx.doi.org/
  • Johansson, Patricia; Laguna, Teresa; Ossowski, Julio; Pancaldi, Vera; Brauser, Martina; Dührsen, Ulrich; Keuneke, Lara; Queiros, Ana; Richter, Julia; Martín-Subero, José I.; Siebert, Reiner; Schlegelberger, Brigitte; Küppers, Ralf; Dürig, Jan; Murga Penas, Eva M.; Carillo-de Santa Pau, Enrique; Bergmann, Anke K.
    Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
    In: Clinical Epigenetics Jg. 14 (2022) Nr. 1, 148
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Denker, Sophy; Bittner, Aitomi; Frick, Mareike; Kase, Julia; Hoffmann, Jörg; Trenker, Corinna; Keller, Ulrich; Bogner, Christian; Hüttmann, Andreas; Dürig, Jan; Janz, Martin; Mathas, Stephan; Marks, Reinhard; Krohn, Ulrike; Na, Il-Kang; Bullinger, Lars; Schmitt, Clemens A.
    Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma : First analysis of toxicity and efficacy signals
    In: Leukemia and Lymphoma Jg. 63 (2022) Nr. 1, S. 84 - 92
    Online Volltext: dx.doi.org/
  • Huber, Henriette; Edenhofer, Simone; von Tresckow, Julia; Robrecht, Sandra; Zhang, Can; Tausch, Eugen; Schneider, Christof; Bloehdorn, Johannes; Fürstenau, Moritz; Dreger, Peter; Ritgen, Matthias; Illmer, Thomas; Illert, Anna L.; Dürig, Jan; Böttcher, Sebastian; Niemann, Carsten U.; Kneba, Michael; Fink, Anna-Maria; Fischer, Kirsten; Döhner, Hartmut; Hallek, Michael; Eichhorst, Barbara; Stilgenbauer, Stephan
    Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia
    In: Blood Jg. 139 (2022) Nr. 9, S. 1318 - 1329
    Online Volltext: dx.doi.org/ (Open Access)
  • Richardson, Paul G.; Schjesvold, Fredrik; Weisel, Katja; Moreau, Philippe; Anderson, Larry D.; White, Darrell; Rodriguez-Otero, Paula; Sonneveld, Pieter; Engelhardt, Monika; Jenner, Matthew; Corso, Alessandro; Dürig, Jan; Pavic, Michel; Salomo, Morten; Beksac, Meral; Oriol, Albert; Lindsay, Jindriska; Liberati, Anna Marina; Galli, Monica; Robak, Pawel; Larocca, Alessandra; Yagci, Munci; Vural, Filiz; Kanate, Abraham S.; Jiang, Ruiyun; Grote, Lara; Peluso, Teresa; Dimopoulos, Meletios
    Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma : A subanalysis of OPTIMISMM by clinical characteristics
    In: European Journal of Haematology Jg. 108 (2022) Nr. 1, S. 73 - 83
    Online Volltext: dx.doi.org/ (Open Access)
  • D'Agostino, Mattia; Cairns, David A.; Lahuerta, Juan José; Wester, Ruth; Bertsch, Uta; Waage, Anders; Zamagni, Elena; Mateos, María-Victoria; Dall'olio, Daniele; Van De Donk, Niels W.C.J.; Jackson, Graham; Rocchi, Serena; Salwender, Hans; Bladé Creixenti, Joan; Van Der Holt, Bronno; Castellani, Gastone; Bonello, Francesca; Capra, Andrea; Mai, Elias K.; Dürig, Jan; Gay, Francesca; Zweegman, Sonja; Cavo, Michele; Kaiser, Martin F.; Goldschmidt, Hartmut; Hernández Rivas, Jesús María; Larocca, Alessandra; Cook, Gordon; San-Miguel, Jesús F.; Boccadoro, Mario; Sonneveld, Pieter
    Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma : A European Myeloma Network (EMN) Report Within the HARMONY Project
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 29, S. 3406 - 3418
    Online Volltext: dx.doi.org/ (Open Access)
  • Dürig, Jan; Uhlig, Jens; Gerhardt, Anke; Ritter, Markus; Hapke, Gunnar; Heßling, Jörg; Staib, Peter; Wolff, Frieder; Krumm, Katja; Fischer von Weikersthal, Ludwig
    Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma : Final results of the non‐interventional study MabSCale
    In: Cancer Medicine Jg. 12 (2022) Nr. 3, S. 2739 - 2751
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Patil, Paurnima; Hillebrecht, Sina; Chteinberg, Emil; López Macias, Cristina; Toprak, Umut H.; Seufert, Julian; Bernhart, Stephan H.; Kretzmer, Helene; Bergmann, Anke K.; Bens, Susanne; Högel, Josef; Müller, Annika; Jebaraj, Billy Michael; Schrader, Alexandra; Johansson, Patricia; Costa, Dolors; Schlesner, Matthias; Dürig, Jan; Herling, Marco; Campo, Elias; Stilgenbauer, Stephan; Wiehle, Laura; Siebert, Reiner
    T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level
    In: Genes, Chromosomes and Cancer Jg. 61 (2022) Nr. 7, S. 432 - 436
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Ohlwein, Simone; Hennig, Frauke; Lucht, Sarah; Schmidt, Börge; Eisele, Lewin; Arendt, Marina; Dührsen, Ulrich; Dürig, Jan; Jöckel, Karl-Heinz; Moebus, Susanne; Hoffmann, Barbara
    Air pollution and polyclonal elevation of serum free light chains : An assessment of adaptive immune responses in the prospective heinz nixdorf recall study
    In: Environmental Health Perspectives Jg. 129 (2021) Nr. 2, S. 027004
    Online Volltext: dx.doi.org/ (Open Access)
  • Cramer, Paula; von Tresckow, Julia; Robrecht, Sandra; Bahlo, Jasmin; Fürstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J.; Vehling-Kaiser, Ursula; Dürig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Böttcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
    Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia : Primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
    In: Haematologica / The Hematology Journal Jg. 106 (2021) Nr. 2, S. 543 - 554
    Online Volltext: dx.doi.org/ (Open Access)
  • Mai, Elias K.; Miah, Kaya; Bertsch, Uta; Dürig, Jan; Scheid, Christof; Weisel, Katja C.; Kunz, Christina; Munder, Markus; Lindemann, Hans-Walter; Merz, Maximilian; Hose, Dirk; Jauch, Anna; Seckinger, Anja; Luntz, Steffen; Sauer, Sandra; Fuhrmann, Stephan; Brossart, Peter; Elmaagacli, Ahmet; Goerner, Martin; Bernhard, Helga; Hoffmann, Martin; Raab, Marc S.; Blau, Igor W.; Hänel, Mathias; Benner, Axel; Salwender, Hans J.; Goldschmidt, Hartmut
    Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
    In: Leukemia Jg. 35 (2021) Nr. 3, S. 809 - 822
    Online Volltext: dx.doi.org/ (Open Access)
  • Budeus, Bettina; Kibler, Artur; Brauser, Martina; Homp, Ekaterina; Bronischewski, Kevin; Ross, J. Alexander; Görgens, Andre; Weniger, Marc; Dunst, Josefine; Kreslavsky, Taras; da Conceição Castro, Symone Vitoriano; Murke, Florian; Oakes, Christopher C.; Rusch, Peter; Andrikos, Dimitrios; Kern, Peter; Köninger, Angela; Lindemann, Monika; Johansson, Patricia; Hansen, Wiebke; Lundell, Anna-Carin; Rudin, Anna; Dürig, Jan; Giebel, Bernd; Hoffmann, Daniel; Küppers, Ralf; Seifert, Marc
    Human cord blood b cells differ from the adult counterpart by conserved ig repertoires and accelerated response dynamics
    In: The Journal of Immunology (JI) Jg. 206 (2021) Nr. 12, S. 2839 - 2851
    Online Volltext: dx.doi.org/ (Open Access)
  • Oubari, Sara; Naser, Eyad; Papathanasiou, Maria; Lüdike, Peter; Hagenacker, Tim; Thimm, Andreas; Rischpler, Christoph; Kessler, Lukas; Kimmich, Christoph; Hegenbart, Ute; Schönland, Stefan; Rassaf, Tienush; Reinhardt, Christian; Jöckel, Karl-Heinz; Dürig, Jan; Dührsen, Ulrich; Carpinteiro, Alexander
    Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvement
    In: European Journal of Haematology Jg. 107 (2021) Nr. 4, S. 449 - 457
    Online Volltext: dx.doi.org/ (Open Access)
  • Baertsch, Marc-Andrea; Mai, Elias K.; Hielscher, Thomas; Bertsch, Uta; Salwender, Hans J.; Munder, Markus; Fuhrmann, Stephan; Dührsen, Ulrich; Brossart, Peter; Neben, Kai; Schlenzka, Jana; Kunz, Christina; Raab, Marc S.; Hillengaß, Jens; Jauch, Anna; Seckinger, Anja; Hose, Dirk; Luntz, Steffen; Sonneveld, Pieter; Lokhorst, Henk; Martin, Hans; Goerner, Martin; Hoffmann, Martin; Lindemann, Hans-Walter; Bernhard, Helga; Blau, Igor W.; Scheid, Christof; Besemer, Britta; Weisel, Katja C.; Hänel, Mathias; Dürig, Jan; Goldschmidt, Hartmut
    Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
    In: Blood Cancer Journal Jg. 11 (2021) Nr. 1, S. 1
    Online Volltext: dx.doi.org/ (Open Access)
  • Salwender, Hans; Elmaagacli, Ahmet; Merz, Maximilian; Miah, Kaya; Benner, Axel; Haenel, Mathias; Jehn, Christian; Mai, Elias K.; Bertsch, Uta; Blau, Igor W.; Scheid, Christof; Hose, Dirk; Seckinger, Anja; Jauch, Anna; Raab, Marc S.; Luntz, Steffen P.; Besemer, Britta; Munder, Markus; Brossart, Peter; Fuhrmann, Stephan; Lindemann, Hans-Walter; Weisel, Katja; Duerig, Jan; Goldschmidt, Hartmut
    Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial
    In: Leukemia (2021)
    Online Volltext: dx.doi.org/
  • Hornung, Nicola; Frank, Mirjam; Dragano, Nico; Dürig, Jan; Dührsen, Ulrich; Moebus, Susanne; Erbel, Raimund; Stang, Andreas; Jöckel, Karl-Heinz; Schmidt, Börge
    Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study
    In: Scientific Reports Jg. 11 (2021) Nr. 1, 19266
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Klein, Eva-Maria; Tichy, Diana; Salwender, Hans J.; Mai, Elias K.; Dürig, Jan; Weisel, Katja C.; Benner, Axel; Bertsch, Uta; Akhavanpoor, Mabast; Besemer, Britta; Munder, Markus; Lindemann, Hans-Walter; Hose, Dirk; Seckinger, Anja; Luntz, Steffen; Jauch, Anna; Elmaagacli, Ahmet; Fuhrmann, Stephan; Brossart, Peter; Goerner, Martin; Bernhard, Helga; Raab, Marc S.; Blau, Igor W.; Haenel, Mathias; Scheid, Christof; Goldschmidt, Hartmut
    Prognostic impact of serum free light chain ratio normalization in patients with multiple myeloma treated within the GMMG-MM5 trial
    In: Cancers Jg. 13 (2021) Nr. 19, 4856
    Online Volltext: dx.doi.org/ (Open Access)
  • Subramaniam, Nirojah; Bottek, Jenny; Thiebes, Stephanie; Zec, Kristina; Kudla, Matthias; Soun, Camille; Panal, Elena De Dios; Lill, Julia K.; Pfennig, Aaron; Herrmann, Ralf; Bruderek, Kirsten; Rahmann, Sven; Brandau, Sven; Johansson, Patricia; Reinhardt, Christian; Dürig, Jan; Seiffert, Martina; Bracht, Thilo; Sitek, Barbara; Engel, Daniel Robert
    Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infections
    In: Blood Advances Jg. 5 (2021) Nr. 5, S. 1259 - 1272
    Online Volltext: dx.doi.org/ (Open Access)
  • Mai, Elias K.; Miah, Kaya; Bertsch, Uta; Dürig, Jan; Scheid, Christof; Weisel, Katja C.; Kunz, Christina; Munder, Markus; Lindemann, Hans-Walter; Merz, Maximilian; Hose, Dirk; Jauch, Anna; Seckinger, Anja; Luntz, Steffen; Sauer, Sandra; Fuhrmann, Stephan; Brossart, Peter; Elmaagacli, Ahmet; Goerner, Martin; Bernhard, Helga; Hoffmann, Martin; Raab, Marc S.; Blau, Igor W.; Hänel, Mathias; Benner, Axel; Salwender, Hans J.; Goldschmidt, Hartmut
    Publisher Correction : Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
    In: Leukemia Jg. 35 (2021) Nr. 12, S. 3636
    Online Volltext: dx.doi.org/ (Open Access)
  • Al-Sawaf, O.; Robrecht, S.; Bahlo, J.; Fink, A.M.; Cramer, P.; v Tresckow, J.; Lange, E.; Kiehl, M.; Dreyling, M.; Ritgen, M.; Dürig, Jan; Tausch, E.; Schneider, C.; Stilgenbauer, S.; Wendtner, C.M.; Fischer, K.; Goede; Hallek, M.; Eichhorst, B.
    Richter transformation in chronic lymphocytic leukemia (CLL) : a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
    In: Leukemia Jg. 35 (2021) Nr. 1, S. 169 - 176
    Online Volltext: dx.doi.org/
  • Awwad, Mohamed H. S.; Mahmoud, Abdelrahman; Bruns, Heiko; Echchannaoui, Hakim; Kriegsmann, Katharina; Lutz, Raphael; Raab, Marc S.; Bertsch, Uta; Munder, Markus; Jauch, Anna; Weisel, Katja; Maier, Bettina; Weinhold, Niels; Salwender, Hans Jürgen; Eckstein, Volker; Hänel, Mathias; Fenk, Roland; Dürig, Jan; Brors, Benedikt; Benner, Axel; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hundemer, Michael
    Selective elimination of immunosuppressive T cells in patients with multiple myeloma
    In: Leukemia Jg. 35 (2021) Nr. 9, S. 2602 - 2615
    Online Volltext: dx.doi.org/ (Open Access)
  • Johansson, Patricia; Dierichs, Laura; Klein-Hitpaß, Ludger; Bergmann, Anke K.; Möllmann, Michael; Menninger, Sascha; Habenberger, Peter; Klebl, Bert; Siveke, Jens; Dührsen, Ulrich; Choidas, Axel; Dürig, Jan
    Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemia
    In: Therapeutic Advances in Hematology Jg. 11 (2020) S. 1 - 15
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Dampmann, Maria; Görgens, André; Möllmann, Michael; Murke, Florian; Dührsen, Ulrich; Giebel, Bernd; Dürig, Jan
    CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivo
    In: PLoS ONE Jg. 15 (2020) Nr. 2, S. e0228674
    Online Volltext: dx.doi.org/ (Open Access)
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Budeus, Bettina; Kuhn, Matthias; Lauber, Chris; Seifert, Michael; Roeder, Ingo; Pförtner, Roman; Stuschke, Martin; Dührsen, Ulrich; Eckstein, Anja; Dürig, Jan; Küppers, Ralf
    Identifying genetic lesions in ocular adnexal extranodal marginal zone lymphomas of the malt subtype by whole genome, whole exome and targeted sequencing
    In: Cancers Jg. 12 (2020) Nr. 4, S. 986
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Röth, Alexander; Möllmann, Michael; Reinhardt, Hans Christian; Dührsen, Ulrich; Dürig, Jan
    Mutations in PIGA cause a CD52-/GPI-anchor-deficient phenotype complicating alemtuzumab treatment in T-cell prolymphocytic leukemia
    In: European Journal of Haematology Jg. 105 (2020) Nr. 6, S. 786 - 796
    Online Volltext: dx.doi.org/ (Open Access)
  • Oberbeck, S.; Schrader, A.; Warner, K.; Jungherz, D.; Crispatzu, G.; von Jan, J.; Chmielewski, M.; Ianevski, A.; Diebner, H.H.; Mayer, P.; Ados, A. Kondo; Wahnschaffe, L.; Braun, T.; Müller, T.A.; Wagle, P.; Bouska, A.; Neumann, T.; Pützer, S.; Varghese, L.; Pflug, N.; Thelen, M.; Makalowski, J.; Riet, N.; Göx, H.J.M.; Rappl, G.; Altmüller, J.; Kotrová, M.; Persigehl, T.; Hopfinger, G.; Hansmann, M.L.; Schlößer, H.; Stilgenbauer, S.; Dürig, Jan; Mougiakakos, D.; von Bergwelt-Baildon, M.; Roeder, I.; Hartmann, S.; Hallek, M.; Moriggl, R.; Brüggemann, M.; Aittokallio, T.; Iqbal, J.; Newrzela, S.; Abken, H.; Herling, M.
    Noncanonical effector functions of the T-memory–like T-PLL cell are shaped by cooperative TCL1A and TCR signaling
    In: Blood Jg. 136 (2020) Nr. 24, S. 2786 - 2802
    Online Volltext: dx.doi.org/ (Open Access)
  • Patil, Paurnima; Cieslak, Agata; Bernhart, Stephan H.; Toprak, Umut H.; Wagener, Rabea; López, Cristina; Wiehle, Laura; Bens, Susanne; Altmüller, Janine; Franitza, Marek; Scholz, Ingrid; Jayne, Sandrine; Ahearne, Matthew J.; Scheffold, Annika; Jebaraj, Billy M. C.; Schneider, Christof; Costa, Dolors; Braun, Till; Schrader, Alexandra; Campo, Elias; Dyer, Martin J. S.; Nürnberg, Peter; Dürig, Jan; Johansson, Patricia; Böttcher, Sebastian; Schlesner, Matthias; Herling, Marco; Stilgenbauer, Stephan; Macintyre, Elizabeth; Siebert, Reiner
    Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemia
    In: Genes, Chromosomes and Cancer Jg. 59 (2020) Nr. 4, S. 261 - 267
    Online Volltext: dx.doi.org/ (Open Access)
  • Goldschmidt, Hartmut; Mai, Elias K.; Dürig, Jan; Scheid, Christof; Weisel, Katja C.; Kunz, Christina; Bertsch, Uta; Hielscher, Thomas; Merz, Maximilian; Munder, Markus; Lindemann, Hans-Walter; Hügle-Dörr, Barbara; Tichy, Diana; Giesen, Nicola; Hose, Dirk; Seckinger, Anja; Huhn, Stefanie; Luntz, Steffen; Jauch, Anna; Elmaagacli, Ahmet; Rabold, Bernhard; Fuhrmann, Stephan; Brossart, Peter; Goerner, Martin; Bernhard, Helga; Hoffmann, Martin; Hillengass, Jens; Raab, Marc S.; Blau, Igor W.; Hänel, Mathias; Salwender, Hans J.
    Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial
    In: Leukemia Jg. 34 (2020) Nr. 7, S. 1853 - 1865
    Online Volltext: dx.doi.org/
  • Weisel, Katja C.; Scheid, Christof; Zago, Manola; Besemer, Britta; Mai, Elias K.; Haenel, Mathias; Dürig, Jan; Munder, Markus; Lindemann, Hans-Walter; Seckinger, Anja; Kunz, Christina; Benner, Axel; Hose, Dirk; Jauch, Anna; Salwender, Hans; Goldschmidt, Hartmut
    Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone : results of the phase II PERSPECTIVE Multiple Myeloma trial
    In: Blood Cancer Journal Jg. 9 (2019) Nr. 4, S. 45
    Online Volltext: dx.doi.org/ (Open Access)
  • Kriegsmann, Katharina; Baertsch, Marc-Andrea; Awwad, Mohamed H. S.; Merz, Maximilian; Hose, Dirk; Seckinger, Anja; Jauch, Anna; Becker, Natalia; Benner, Axel; Raab, Marc S.; Hillengass, Jens; Bertsch, Uta; Dürig, Jan; Salwender, Hans Jürgen; Hänel, Mathias; Fenk, Roland; Munder, Markus; Weisel, Katja; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hundemer, Michael
    Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients
    In: Blood Cancer Journal Jg. 9 (2019) Nr. 2, S. 13
    Online Volltext: dx.doi.org/ (Open Access)
  • Leeksma, Alexander C.; Taylor, Justin; Wu, Bian; Gardner, Jeffrey R.; He, Jie; Nahas, Michelle; Gonen, Mithat; Alemayehu, Wendimagegn G.; te Raa, Doreen; Walther, Tatjana; Hüllein, Jennifer; Dietrich, Sascha; Claus, Rainer; de Boer, Fransien; de Heer, Koen; Dubois, Julie; Dampmann, Maria; Dürig, Jan; van Oers, Marinus H. J.; Geisler, Christian H.; Eldering, Eric; Levine, Ross L.; Miller, Vincent; Mughal, Tariq; Lamanna, Nicole; Frattini, Mark G.; Heaney, Mark L.; Zelenetz, Andrew; Zenz, Thorsten; Abdel-Wahab, Omar; Kater, Arnon P.
    Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia
    In: Leukemia Jg. 33 (2019) Nr. 2, S. 390 - 402
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Merz, Maximilian; Hielscher, Thomas; Mai, Elias Karl; Seckinger, Anja; Hose, Dirk; Jauch, Anna; Sauer, Sandra; Luntz, Steffen; Bertsch, Uta; Raab, Marc S.; Neben, Kai; Salwender, Hans; Blau, Igor W.; Lindemann, Hans-Walter; Dürig, Jan; Scheid, Christof; Haenel, Mathias; Weisel, Katja; Weber, Tim; Delorme, Stefan; Goldschmidt, Hartmut; Hillengass, Jens
    Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma
    In: Blood Cancer Journal Jg. 9 (2019) Nr. 9, S. 71
    Online Volltext: dx.doi.org/ (Open Access)
  • Radtke, Stefan; Görgens, André; Vitoriano da Conceição Castro, Symone; Kordelas, Lambros; Köninger, Angela; Dürig, Jan; Möllmann, Michael; Horn, Peter; Giebel, Bernd
    Human multipotent hematopoietic progenitor cell expansion is neither supported in endothelial and endothelial/mesenchymal co-cultures nor in NSG mice
    In: Scientific Reports Jg. 9 (2019) S. 12914
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Wahnschaffe, Linus; Braun, Till; Timonen, Sanna; Giri, Anil K.; Schrader, Alexandra; Wagle, Prerana; Almusa, Henrikki; Johansson, Patricia; Bellanger, Dorine; López, Cristina; Haferlach, Claudia; Stern, Marc-Henri; Dürig, Jan; Siebert, Reiner; Mustjoki, Satu; Aittokallio, Tero; Herling, Marco
    JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL
    In: Cancers Jg. 11 (2019) Nr. 12, S. 1833
    Online Volltext: dx.doi.org/ (Open Access)
  • Pflug, Natali; Cramer, Paula; Robrecht, Sandra; Bahlo, Jasmin; Westermann, Anne; Fink, Anna-Maria; Schrader, Alexandra; Mayer, Petra; Oberbeck, Sebastian; Seiler, Till; Zenz, Thorsten; Dürig, Jan; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Herling, Marco; Hopfinger, Georg
    New lessons learned in T-PLL : results from a prospective phase-II trial with fludarabine–mitoxantrone–cyclophosphamide–alemtuzumab induction followed by alemtuzumab maintenance
    In: Leukemia and Lymphoma Jg. 60 (2019) Nr. 3, S. 649 - 657
    Online Volltext: dx.doi.org/
  • Haas, Eva-Maria; Salwender, Hans J.; Mai, Elias K.; Dürig, Jan; Weisel, Katja; Tichy, Diana; Benner, Axel; Kunz, Christina; Hielscher, Thomas; Bertsch, Uta; Besemer, Britta; Merz, Maximilian; Munder, Markus; Lindemann, Hans-Walter; Hügle-Dörr, Barbara; Giessen, Nicola; Hose, Dirk; Seckinger, Anja; Huhn, Stefanie; Luntz, Steffen; Jauch, Anna; Elmaagacli, Ahmet; Rabold, Bernhard; Fuhrmann, Stephan; Brossart, Peter; Goerner, Martin; Bernhard, Helga; Hoffmann, Martin; Hillengass, Jens; Raab, Marc S.; Blau, Igor Wolfgang; Haenel, Mathias; Scheid, Christof; Goldschmidt, Hartmut;
    Normalization of serum free light chains during therapy in the MM5 trial predicts prolonged progression free survival and overall survival
    17th International Myeloma Workshop ; September 12-15, 2019, Boston, MA, USA,
    In: Clinical Lymphoma, Myeloma & Leukemia Jg. 19 (2019) Nr. 10, Suppl., S. e208
    Online Volltext: dx.doi.org/
  • Salwender, Hans; Bertsch, Uta; Weisel, Katja; Dürig, Jan; Kunz, Christina; Benner, Axel; Blau, Igor W.; Raab, Marc Steffen; Hillengass, Jens; Hose, Dirk; Huhn, Stefanie; Hundemer, Michael; Andrulis, Mindaugas; Jauch, Anna; Seidel-Glaetzer, Andrea; Lindemann, Hans-Walter; Hensel, Manfred; Fronhoffs, Stefan; Martens, Uwe; Hansen, Timon; Wattad, Mohammed; Graeven, Ullrich; Munder, Markus; Fenk, Roland; Haenel, Mathias; Scheid, Christof; Goldschmidt, Hartmut
    Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6 : A randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma
    In: BMC Cancer Jg. 19 (2019) Nr. 1, S. 504
    Online Volltext: dx.doi.org/ (Open Access)
  • Hüttmann, Andreas; Rekowski, Jan; Müller, Stefan; Hertenstein, Bernd; Franzius, Christiane; Mesters, Rolf; Weckesser, Matthias; Kroschinsky, Frank; Kotzerke, Jörg; Ganser, Arnold; Bengel, Frank M.; La Rosée, Paul; Freesmeyer, Martin; Höffkes, Heinz-Gert; Hertel, Andreas; Behringer, Dirk; Prange-Krex, Gabriele; Griesshammer, Martin; Holzinger, Jens; Wilop, Stefan; Krohn, Thomas; Raghavachar, Aruna; Maschmeyer, Georg; Brink, Ingo; Schroers, Roland; Gaska, Tobias; Bernhard, Helga; Giagounidis, Aristoteles; Schütte, Jochen; Dienst, Ariane; Hautzel, Hubertus; Naumann, Ralph; Klein, Alfred; Hahn, Dennis; Pöpperl, Gabriele; Grube, Matthias; Marienhagen, Jörg; Schwarzer, Andreas; Kurch, Lars; Höhler, Thomas; Steiniger, Heike; Nückel, Holger; Südhoff, Thomas; Römer, Wolfgang; Brinkmann, Marcus; Ose, Claudia; Alashkar, Ferras; Schmitz, Christine; Dürig, Jan; Hoelzer, Dieter; Jöckel, Karl-Heinz; Klapper, Wolfram; Dührsen, Ulrich
    Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP : results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial
    In: Annals of Hematology Jg. 98 (2019) Nr. 4, S. 897 - 907
    Online Volltext: dx.doi.org/
  • Schmidt, Börge; Debold, Elisabeth; Frank, Mirjam; Arendt, Marina; Dragano, Nico; Dürig, Jan; Dührsen, Ulrich; Moebus, Susanne; Erbel, Raimund; Jöckel, Karl-Heinz; Eisele, Lewin
    Socioeconomic Position is Positively Associated with Monoclonal Gammopathy of Undetermined Significance in a Population-based Cohort Study
    In: Annals of Hematology Jg. 98 (2019) Nr. 12, S. 2761 - 2767
    Online Volltext: dx.doi.org/
  • König, Laila; Dreyling, Martin; Dürig, Jan; Engelhard, Marianne; Hohloch, Karin; Viardot, Andreas; Witzens-Harig, Mathias; Kieser, Meinhard; Klapper, Wolfram; Pott, Christiane; Herfarth, Klaus
    Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy) : A study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial
    In: Trials Jg. 20 (2019) Nr. 1, S. 544
    Online Volltext: dx.doi.org/ (Open Access)
  • Tucci, Felicia A.; Kitanovski, Simo; Johansson, Patricia; Klein-Hitpaß, Ludger; Kahraman, Alisan; Dürig, Jan; Hoffmann, Daniel; Küppers, Ralf
    Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus–infected individuals
    In: Blood Jg. 131 (2018) Nr. 5, S. 546 - 557
    Online Volltext: dx.doi.org/ (Open Access)
  • Dietrich, Sascha; Oleś, Małgorzata; Lu, Junyan; Sellner, Leopold; Anders, Simon; Velten, Britta; Wu, Bian; Hüllein, Jennifer; Liberio, Michelle da Silva; Walther, Tatjana; Wagner, Lena; Rabe, Sophie; Ghidelli-Disse, Sonja; Bantscheff, Marcus; Oleś, Andrzej K.; Słabicki, Mikołaj; Mock, Andreas; Oakes, Christopher C.; Wang, Shihui; Oppermann, Sina; Lukas, Marina; Kim, Vladislav; Sill, Martin; Benner, Axel; Jauch, Anna; Sutton, Lesley Ann; Young, Emma; Rosenquist, Richard; Liu, Xiyang; Jethwa, Alexander; Lee, Kwang Seok; Lewis, Joe; Putzker, Kerstin; Lutz, Christoph; Rossi, Davide; Mokhir, Andriy; Oellerich, Thomas; Zirlik, Katja; Herling, Marco; Nguyen-Khac, Florence; Plass, Christoph; Andersson, Emma; Mustjoki, Satu; Von Kalle, Christof; Ho, Anthony D.; Hensel, Manfred; Dürig, Jan; Ringshausen, Ingo; Zapatka, Marc; Huber, Wolfgang; Zenz, Thorsten
    Drug-perturbation-based stratification of blood cancer
    In: The Journal of Clinical Investigation (JCI) Jg. 128 (2018) Nr. 1, S. 427 - 445
    Online Volltext: dx.doi.org/ (Open Access)
  • Balser, Christina; Lerchenmüller, Christian; Koenigsmann, Michael; Maschmeyer, Georg; Kaiser, Ulrich; Lange, Elisabeth; Behringer, Dirk; Kauff, Frank; Dürig, Jan; Greil, Richard; Barth, Juergen; Gaska, Tobias; Burchardt, Alexander C.; Reeb, Manfred; Rummel, Mathias; Hertenstein, Bernd; Buske, Christian; Schliesser, Georg; Hinke, Axel;
    Four versus Two Years of Rituximab Maintenance (R-Maintenance) Following Bendamustine Plus Rituximab (B-R) : Results of a Prospective, Randomized Multicenter Phase 3 Study in First-Line Follicular Lymphoma (the StiL NHL7-2008 MAINTAIN Study)
    Society of Hematologic Oncology 6th Annual Meeting (SOHO) ; September 12-15, 2018, Houston, Texas, USA,
    In: Clinical Lymphoma, Myeloma & Leukemia Jg. 18 (2018) Nr. Suppl. 1, S. S101 - S103
    Online Volltext: dx.doi.org/
  • Hiddemann, Wolfgang; Barbui, Anna Maria; Canales, Miguel A.; Cannell, Paul K.; Collins, Graham P.; Dürig, Jan; Forstpointner, Roswitha; Herold, Michael; Hertzberg, Mark; Klanova, Magdalena; Radford, John; Seymour, John F.; Tobinai, Kensei; Trotman, Judith; Burciu, Alis; Fingerle-Rowson, Günter; Wolbers, Marcel; Nielsen, Tina; Marcus, Robert E.
    Immunochemotherapy with obinutuzumab or rituximab for previously untreated follicular lymphoma in the GALLIUM study : Influence of chemotherapy on efficacy and safety
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 23, S. 2395 - 2404
    Online Volltext: dx.doi.org/ (Open Access)
  • Pelzer, Benedikt W.; Arendt, Marina; Moebus, Susanne; Eisele, Lewin; Jöckel, Karl-Heinz; Dührsen, Ulrich; Dürig, Jan
    Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis
    In: Annals of Hematology Jg. 97 (2018) Nr. 8, S. 1463 - 1469
    Online Volltext: dx.doi.org/
  • Merz, Maximilian; Hielscher, T.; Seckinger, A.; Jauch, A.; Bertsch, U.; Raab, M.S.; Neben, K.; Salwender, H.; Blau, I.W.; Lindemann, H.W.; Dürig, Jan; Scheid, C.; Haenel, M.; Weisel, K.; Delorme, S.; Kauczor, H.U.; Hose, D.; Goldschmidt, H.; Hillengass, J.
    Magnetic resonance imaging before and after upfront autologous transplantation identifies patients with adverse outcome but response to treatment within the prospective GMMG MM5 phase III trial
    In: Haematologica / The Hematology Journal Jg. 103 (2018) Nr. Suppl. 1, S. 11 - 12
  • Mangolini, Maurizio; Götte, Frederik; Moore, Andrew; Ammon, Tim; Oelsner, Madlen; Lutzny-Geier, Gloria; Klein-Hitpaß, Ludger; Williamson, James C.; Lehner, Paul J.; Dürig, Jan; Möllmann, Michael; Rásó-Barnett, Lívia; Hughes, Katherine; Santoro, Antonella; Méndez-Ferrer, Simón; Oostendorp, Robert A. J.; Zimber-Strobl, Ursula; Peschel, Christian; Hodson, Daniel J.; Schmidt-Supprian, Marc; Ringshausen, Ingo
    Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia
    In: Nature Communications Jg. 9 (2018) S. 3839
    Online Volltext: dx.doi.org/ (Open Access)
  • Dührsen, Ulrich; Müller, Stefan; Hertenstein, Bernd; Thomssen, Henrike; Kotzerke, Jörg; Mesters, Rolf; Berdel, Wolfgang E.; Franzius, Christiane; Kroschinsky, Frank; Weckesser, Matthias; Kofahl-Krause, Dorothea; Bengel, Frank M.; Dürig, Jan; Matschke, Johannes; Schmitz, Christine; Pöppel, Thorsten; Ose, Claudia; Brinkmann, Marcus; La Rosée, Paul; Freesmeyer, Martin; Hertel, Andreas; Höffkes, Heinz-Gert; Behringer, Dirk; Prange-Krex, Gabriele; Wilop, Stefan; Krohn, Thomas; Holzinger, Jens; Griesshammer, Martin; Giagounidis, Aristoteles; Raghavachar, Aruna; Maschmeyer, Georg; Brink, Ingo; Bernhard, Helga; Haberkorn, Uwe; Gaska, Tobias; Kurch, Lars; Van Assema, Daniëlle M.E.; Klapper, Wolfram; Hoelzer, Dieter; Geworski, Lilli; Jöckel, Karl-Heinz; Scherag, Andre; Bockisch, Andreas; Rekowski, Jan; Hüttmann, Andreas
    Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) : A Multicenter, Randomized Phase III Trial
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 20, S. 2024 - 2034
    Online Volltext: dx.doi.org/ (Open Access)
  • Göthert, Joachim Rudolf; Imsak, Roze; Möllmann, Michael; Kesper, Stefanie; Göbel, Maria; Dührsen, Ulrich; Scholz, Arne; Lücking, Ulrich; Baumann, Matthias; Unger, Anke; Schultz-Fademrecht, Carsten; Klebl, Bert; Eickhoff, Jan; Choidas, Axel; Dürig, Jan
    Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia
    In: OncoTarget Jg. 9 (2018) Nr. 41, S. 26353 - 26369
    Online Volltext: dx.doi.org/ (Open Access)
  • Herfarth, Klaus; Borchmann, Peter; Schnaidt, Sven; Hohloch, Karin; Budach, Volker; Engelhard, Marianne; Viardot, Andreas; Engenhart-Cabillic, Rita; Keller, Ulrich; Reinartz, Gabriele; Eich, Hans-Theodor; Witzens-Harig, Mathias; Hess, Clemens F.; Dörken, Bernd; Dürig, Jan; Wiegel, Thomas; Hiddemann, Wolfgang; Hoster, Eva; Pott, Christiane; Dreyling, Martin
    Rituximab with Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma : Results of the MIR Study
    In: HemaSphere: Open Access Journal of the European Hematology Association Jg. 2 (2018) Nr. 6, S. e160
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Choidas, Axel; Habenberger, Peter; Mahboubi, Bijan; Kim, Baek; Bergmann, Anke; Scholtysik, René; Brauser, Martina; Lollies, Anna; Siebert, Reiner; Zenz, Thorsten; Dührsen, Ulrich; Küppers, Ralf; Dürig, Jan
    SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia
    In: Blood Cancer Journal Jg. 8 (2018) Nr. 1, S. 11
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Awwad, Mohamed H. S.; Kriegsmann, Katharina; Plaumann, Julian; Benn, Michael; Hillengass, Jens; Raab, Marc S.; Bertsch, Uta; Munder, Markus; Weisel, Katja; Salwender, Hans Jürgen; Hänel, Mathias; Fenk, Roland; Dürig, Jan; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hundemer, Michael
    The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma
    In: OncoImmunology Jg. 7 (2018) Nr. 10, e1486356
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Jewell, Roxanne C.; Kipps, Thomas J.; Dürig, Jan; Griskevicius, Laimonas; Stilgenbauer, Stephan; Smolej, Lukáš; Mayer, Jiří; Hess, Georg; Hernandez-Ilizaliturri, Francisco J.; Padmanabhan-Iyer, Swaminathan; Fang, Lei; Goldstein, Nancy; Gorczyca, Michele; Gupta, Ira; Lisby, Steen; Wierda, William G.
    Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy
    In: Leukemia and Lymphoma Jg. 58 (2017) Nr. 2, S. 348 - 356
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Huhn, S.; Weinhold, N.; Nickel, J.; Pritsch, M.; Hielscher, T.; Hummel, M.; Bertsch, U.; Huegle-Doerr, B.; Vogel, M.; Angermund, R.; Hänel, M.; Salwender, H.J.; Weisel, K.; Dürig, Jan; Görner, M.; Kirchner, H.; Peter, N.; Graeven, U.; Lordick, F.; Hoffmann, M.; Reimer, P.; Blau, I.W.; Jauch, A.; Dembowsky, K.; Möhler, T.; Wuchter, P.; Goldschmidt, H.
    Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial
    In: Bone Marrow Transplantation Jg. 52 (2017) Nr. 8, S. 1194 - 1198
    Online Volltext: dx.doi.org/ (Open Access)
  • Schmitt, Michael; Hückelhoven, Angela G; Hundemer, Michael; Schmitt, Anita; Lipp, Susanne; Emde, Martina; Salwender, Hans; Hänel, Mathias; Weisel, Katja; Bertsch, Uta; Dürig, Jan; Ho, Anthony D.; Blau, Igor Wolfgang; Goldschmidt, Hartmut; Seckinger, Anja; Hose, Dirk
    Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial
    In: OncoTarget Jg. 8 (2017) Nr. 49, S. 84847 - 84862
    Online Volltext: dx.doi.org/ (Open Access)
  • da Silva Nardi, Fabiola; Kraemer, Thomas; Dürig, Jan; Rebmann, Vera; Wagner, Bettina; Horn, Peter; Celik, Alexander A.; Nückel, Holger; Schramm, Sabine; Dührsen, Ulrich
    HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia
    In: Cancer Jg. 123 (2017) Nr. 5, S. 814 - 823
    Online Volltext: dx.doi.org/
  • Hiddemann, W.; Barbui, A. M.; Albendea, MAC; Cannell, P. K.; Collins, G. P.; Dürig, Jan; Forstpointner, R.; Herold, M.; Hertzberg, M.; Klanova, M.; Radford, J. A.; Tobinai, K.; Burciu, A.; Fingerle-Rowson, G. R.; Nielsen, T.; Wolbers, M.; Marcus, R. E.
    Immunochemotherapy with obinutuzumab or rituximab in previously untreated follicular lymphoma in the randomized phase III gallium study : analysis by chemotherapy regimen
    In: Haematologica / The Hematology Journal Jg. 102 (2017) Nr. Suppl. 2, S. 314
  • Orban, Ester; Arendt, Marina; Hennig, Frauke; Lucht, Sarah; Eisele, Lewin; Jakobs, Hermann; Dürig, Jan; Hoffmann, Barbara; Jöckel, Karl-Heinz; Moebus, Susanne
    Is long-term particulate matter and nitrogen dioxide air pollution associated with incident monoclonal gammopathy of undetermined significance (MGUS)? : An analysis of the Heinz Nixdorf Recall study
    In: Environment International Jg. 108 (2017) S. 237 - 245
    Online Volltext: dx.doi.org/
  • Pelzer, B. W.; Arendt, Marina; Siegmund, J. M.; Eisele, Lewin; Moebus, Susanne; Jöckel, Karl-Heinz; Dührsen, Ulrich; Dürig, Jan; Heinz Nixdorf Recall Study
    Longitudinal analysis of light-chain monoclonal gammopathy of undetermined significance-10-year follow up of the population-based Heinz Nixdorf Recall study
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, S. 81 Abstract P292
    Online Volltext: dx.doi.org/
  • Mangolini, M.; Gotte, F.; Ammon, T.; Oelsner, M.; Klein-Hitpaß, Ludger; Dürig, Jan; Hughes, K.; Lutzny, G.; Strobl, U.; Ringshausen, I.
    NOTCH-signaling in the tumor microenvironment is required for canonical WNT signaling in CLL cells
    In: Leukemia and Lymphoma Jg. 58 (2017) Nr. Suppl. 1, XVII International Workshop on Chronic Lymphocytic Leukemia 2017 May 12--15, 2017, New York, S. 125 - 126
    Online Volltext: dx.doi.org/
  • Turki, Amin T.; Rashidi-Alavijeh, Jassin; Dürig, Jan; Gerken, Guido; Rath, Peter-Michael; Witzke, Oliver
    Successful treatment of cerebral aspergillosis: Case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL)
    In: BMC Infectious Diseases Jg. 17 (2017) S. 797
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Haderk, Franziska; Schulz, Ralph; Iskar, Murat; Cid, Laura Llaó; Worst, Thomas; Willmund, Karolin V; Schulz, Angela; Warnken, Uwe; Seiler, Jana; Benner, Axel; Nessling, Michelle; Zenz, Thorsten; Göbel, Maria; Dürig, Jan; Diederichs, Sven; Paggetti, Jérôme; Moussay, Etienne; Stilgenbauer, Stephan; Zapatka, Marc; Lichter, Peter; Seiffert, Martina
    Tumor-derived exosomes modulate PD-L1 expression in monocytes
    In: Science Immunology Jg. 2 (2017) Nr. 13,
    Online Volltext: dx.doi.org/
  • Stiefelhagen, Marius; Gigel, Carola; Vasyutina, Elena; Möllmann, Michael; Breuer, Alexandra; Mayer, Petra; Dürig, Jan; Herling, Marco
    Activity of the CD40 antagonistic antibody lucatumumab - insights from CLL-niche mimicking xenografts and fludarabine combinations
    In: Leukemia and Lymphoma Jg. 57 (2016) Nr. 9, S. 2235 - 2238
    Online Volltext: dx.doi.org/
  • Föhring, D.; Dührsen, Ulrich; Hammers, C. M.; Dürig, Jan
    Bendamustine triggered paraneoplastic pemphigus in a patient with chronic lymphocytic leukemia
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 257 - 258
  • Seiffert, M.; Haderk, F.; Cid, L. L.; Gobel, M.; Dürig, Jan; Lichter, P.
    Chronic Lymphocytic Leukemia-Derived Extracellular Vesicles Mediate NF kappa B Signaling and Pro-Inflammatory Cytokine Release in Monocytes
    In: The Journal of Immunology (JI) Jg. 196 (2016) Nr. Suppl. 1, -
  • Haderk, F.; Cid, L. L.; Moussay, E.; Paggetti, J.; Willmund, K.; Seiler, Jonas; Diederichs, S.; Goebell; Dürig, Jan; Zenz, T.; Stilgenbauer, S.; Zapatka, M.; Lichter, P.; Seiffert, M.
    Chronic lymphocytic leukemia-derived extracellular vesicles mediate NFkB signaling and pro-inflammatory cytokine release in monocytes
    In: Cancer Research Jg. 76 15 (2016) -
    Online Volltext: dx.doi.org/
  • Manteniotis, S; Wojcik, S; Göthert, Joachim Rudolf; Dürig, Jan; Dührsen, Ulrich; Gisselmann, G; Hatt, H
    Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells
    In: Cell Death Discovery Jg. 2 (2016) Nr. 1, 16010
    Online Volltext: dx.doi.org/ (Open Access)
  • Goede, Valentin; Bahlo, Jasmin; Chataline, Viktoria; Eichhorst, Barbara; Dürig, Jan; Stilgenbauer, Stephan; Kolb, Gerald; Honecker, Friedemann; Wedding, Ulrich; Hallek, Michael
    Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia : Results of the CLL9 trial of the German CLL study group
    In: Leukemia and Lymphoma Jg. 57 (2016) Nr. 4, S. 789 - 796
    Online Volltext: dx.doi.org/
  • López, Cristina; Bergmann, Anke K; Paul, Ulrike; Murga Penas, Eva M; Nagel, Inga; Betts, Matthew J; Johansson, Patricia; Ritgen, Matthias; Baumann, Tycho; Aymerich, Marta; Jayne, Sandrine; Russell, Robert B; Campo, Elias; Dyer, Martin J S; Dürig, Jan; Siebert, Reiner
    Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia
    In: British Journal of Haematology Jg. 173 (2016) Nr. 2, S. 265 - 273
    Online Volltext: dx.doi.org/
  • Bühler, A; Wendtner, C-M; Kipps, T J; Rassenti, L; Fraser, G A M; Michallet, A-S; Hillmen, P; Dürig, Jan; Gregory, S A; Kalaycio, M; Aurran-Schleinitz, T; Trentin, L; Gribben, J G; Chanan-Khan, A; Purse, B; Zhang, J; De Bedout, S; Mei, J; Hallek, M; Stilgenbauer, S
    Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia : data from the prospective, multicenter phase-II CLL-009 trial
    In: Blood Cancer Journal Jg. 6 (2016) S. e404
    Online Volltext: dx.doi.org/ (Open Access)
  • Merz, Maximilian; Salwender, Hans; Haenel, Mathias; Mai, Elias K; Bertsch, Uta; Kunz, Christina; Hielscher, Thomas; Blau, Igor W; Scheid, Christof; Hose, Dirk; Seckinger, Anja; Jauch, Anna; Hillengass, Jens; Raab, Marc S; Schurich, Baerbel; Munder, Markus; Brossart, Peter; Gerecke, Christian; Lindemann, Hans-Walter; Zeis, Matthias; Weisel, Katja; Dürig, Jan; Goldschmidt, Hartmut
    Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial
    In: Haematologica / The Hematology Journal Jg. 101 (2016) Nr. 12, S. e485 - e487
    Online Volltext: dx.doi.org/ (Open Access)
  • Johansson, Patricia; Bergmann, Anke; Rahmann, Sven; Wohlers, Inken; Scholtysik, René; Przekopowitz, Martina; Seifert, Marc; Tschurtschenthaler, Gertraud; Webersinke, Gerald; Jäger, Ulrich; Siebert, Reiner; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan; Küppers, Ralf
    Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia
    In: International Journal of Cancer Jg. 138 (2016) Nr. 1, S. 121 - 124
    Online Volltext: dx.doi.org/ (Open Access)
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Grabellus, Florian; Arnold, Georg; Klapper, Wolfram; Pförtner, Roman; Dührsen, Ulrich; Eckstein, Anja; Dürig, Jan; Küppers, Ralf
    Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas
    In: OncoTarget Jg. 7 (2016) Nr. 38, S. 62627 - 62639
    Online Volltext: dx.doi.org/ (Open Access)
  • Wendtner, Clemens M.; Hallek, Michael; Fraser, Graeme A. M.; Michallet, Anne-Sophie; Hillmen, Peter; Dürig, Jan; Kalaycio, Matt; Gribben, John G.; Stilgenbauer, Stephan; Buhler, Andreas; Kipps, Thomas J.; Purse, Brendan; Zhang, Jennie; De Bedout, Sabine; Mei, Jay; Chanan-Khan, Asher
    Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial
    In: Leukemia and Lymphoma Jg. 57 (2016) Nr. 6, S. 1291 - 1299
    Online Volltext: dx.doi.org/
  • Dürig, Jan; Azeh, I.; Blumenstengel, K.; Gerhardt, A.; Hanel, M.; Hapke, G.; Hensel, M.; Hessling, J.; Hoffkes, H. G.; Hurtz, H. J.; Ritter, M.; Staib, P.; Uhlig, J.; Marquardt, M.; Krumm, K.; von Weikersthal, L. F.
    Subcutaneous rituximab in patients with DLBCL and follicular NHL - First interim results from the non-interventional study MabSCale
    In: Oncology Research and Treatment Jg. 39 3 (2016) S. 156 - 156
  • Wanger, Bettina; Nardi, FabiolaDaS; Schramm, Sabine; Kraemer, Thomas; Bade-Doeding, Christina; Dürig, Jan; Horn, Peter; Dührsen, Ulrich; Nückel, Holger; Rebmann, Vera
    Elevated levels of soluble HLA-E and the presence of HLA-E*01:03 predict disease of progression in CLL
    In: Tissue Antigens Jg. 86 (2015) Nr. 2, S. 85 - 86
  • Li, Yu; Dürig, Jan; Göbel, Maria; Hanoun, Maher; Klein-Hitpaß, Ludger; Dührsen, Ulrich
    Functional abnormalities and changes in gene expression in fibroblasts and macrophages from the bone marrow of patients with acute myeloid leukemia
    In: International Journal of Hematology Jg. 102 (2015) Nr. 3, S. 278 - 288
    Online Volltext: dx.doi.org/
  • Johansson, Patricia; Dürig, Jan; Rekowski, Jan; Muller, S. P.; Hertenstein, B.; Franzius, C.; Kroschinsky, F.; Kotzerke, J.; Mesters, R.; Weckesser, M.; La Rosee, P.; Freesmeyer, M.; Wilop, S.; Krohn, T.; Dührsen, Ulrich; Hutmann, A.
    Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive Lymphomas
    In: Blood Jg. 126 (2015) Nr. 23,
    Online Volltext
  • Goergens, Andre; Ludwig, Anna-Krist; Moellmann, Michael; Krawczyk, Adalbert; Dürig, Jan; Hanenberg, Helmut; Horn, Peter A.; Giebel, Bernd
    Multipotent Hematopoietic Progenitors Divide Asymmetrically to Create Progenitors of the Lymphomyeloid and Erythromyeloid Lineages
    In: Stem Cell Reports Jg. 5 (2015) Nr. 1, S. 154 - 155
    Online Volltext: dx.doi.org/ (Open Access)
  • Mai, Elias Karl; Bertsch, Uta; Dürig, Jan; Kunz, Christina; Haenel, Mathias; Blau, Igor Wolfgang; Munder, Markus; Jauch, Anna; Schurich, Baerbel; Hielscher, Thomas; Merz, Maximilian; Huegle-Doerr, B.; Seckinger, Anja; Hose, Dirk; Hillengass, Jens; Raab, Marc Steffen; Neben, Kai; Lindemann, Hans Walter; Zeis, Matthias; Gerecke, Christian; Schmidt-Wolf, Ingo G.H.; Weisel, Katja Christina; Scheid, Christof; Salwender, Hans Jürgen; Goldschmidt, Hartmut M.
    Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma
    In: Leukemia Jg. 29 (2015) Nr. 8, S. 1721 - 1729
    Online Volltext: dx.doi.org/
  • Dietrich, Sascha; Hüllein, Jennifer; Lee, Stanley Chun-Wei; Hutter, Barbara; Gonzalez, David; Jayne, Sandrine; Dyer, Martin J. S.; Oleś, Małgorzata; Else, Monica; Liu, Xiyang; Słabicki, Mikołaj; Wu, Bian; Troussard, Xavier; Dürig, Jan; Andrulis, Mindaugas; Dearden, Claire; Kalle, Christof von; Granzow, Martin; Jauch, Anna; Fröhling, Stefan; Huber, Wolfgang; Meggendorfer, Manja; Haferlach, Torsten; Ho, Anthony D.; Richter, Daniela; Brors, Benedikt; Glimm, Hanno; Matutes, Estella; Wahab, Omar Abdel; Zenz, Thorsten
    Recurrent CDKN1B (p27) mutations in hairy cell leukemia
    In: Blood Jg. 126 (2015) Nr. 8, S. 1005 - 1008
    Online Volltext: dx.doi.org/
  • Wagner, Bettina; Nardil, FabiolaDas; Schramm, Sabine; Kraemer, Thomas; Bade-Doeding, Christina; Dürig, Jan; Horn, Peter; Dührsen, Ulrich; Nückel, Holger; Rebmann, Vera
    Soluble HLA-E and HLA-E polymorphism predictors of early disease progression in CLL
    In: Tissue Antigens Jg. 85 (2015) Nr. 5, S. 327 - 328
  • Merz, Maximilian; Salwender, Hans; Haenel, Mathias; Mai, Elias K; Bertsch, Uta; Kunz, Christina; Hielscher, Thomas; Blau, Igor W; Scheid, Christof; Hose, Dirk; Seckinger, Anja; Jauch, Anna; Hillengass, Jens; Raab, Marc S; Schurich, Baerbel; Munder, Markus; Schmidt-Wolf, Ingo G H; Gerecke, Christian; Lindemann, Hans-Walter; Zeis, Matthias; Weisel, Katja; Dürig, Jan; Goldschmidt, Hartmut
    Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma : an interim analysis from the prospective GMMG-MM5 trial
    In: Haematologica / The Hematology Journal Jg. 100 (2015) Nr. 7, S. 964 - 969
    Online Volltext: dx.doi.org/ (Open Access)
  • Wagner, Bettina; Nardi, FabiolaDaS; Schramm, Sabine; Kraemer, Thomas; Bade-Doeding, Christina; Dürig, Jan; Horn, Peter A.; Dührsen, Ulrich; Nueckel, Holger; Rebmann, Vera
    Increases levels of soluble HLA-E are associated with advanced disease stage and early treatment requirement in chronic lymphoytic leukemia
    In: Tissue Antigens Jg. 84 (2014) Nr. 1, S. 139 - 139
  • Gorgens, A.; Ludwig, A. K.; Mollmann, M.; Krawczyk, Adalbert; Dürig, Jan; Hanenberg, H.; Horn, Peter; Giebel, Bernd
    Multipotent hematopoietic progenitors divide asymmetrically to create progenitors of the lymphomyeloid and erythromyeloid lineages
    In: Stem Cell Reports Jg. 3 (2014) Nr. 6, S. 1058 - 1072
    Online Volltext: dx.doi.org/ (Open Access)
  • Langerbeins, Petra; Busch, Raymonde; Anheier, Nadine; Dürig, Jan; Bergmann, Manuela; Goebeler, Maria-Elisabeth; Hurtz, Hans-Jürgen; Stauch, Martina B; Stilgenbauer, Stephan; Döhner, Hartmut; Fink, Anna-Maria; Cramer, Paula; Fischer, Kirsten; Wendtner, Clemens-Martin; Hallek, Michael; Eichhorst, Barbara
    Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation
    In: American Journal of Hematology Jg. 89 (2014) Nr. 12, S. E239 - 43
    Online Volltext: dx.doi.org/ (Open Access)
  • Dührsen, Ulrich; Hüttmann, Andreas; Mueller, Stefan; Hertenstein, Bernd; Kotzerke, Joerg; Mesters, Rolf; Franzius, Christiane; Kroschinsky, Frank; Weckesser, Matthias; Franzke, Anke; Bengel, Frank; Dürig, Jan; Matschke, Johannes; Pöppel, Thorsten; Rekowski, Jan; Ose, Claudia; Brinkmann, Marcus; LaRosee, Paul; Freesmeyer, Martin; Hertel, Andreas; Hoeffkes, Heinz-Gert; Behringer, Dirk; Prange-Krex, Gabriele; Wilop, Stefan; Krohn, Thomas; Fricke, Eva; Griesshammer, Martin; Giagounidis, Aristotele; Raghavachar, Aruna; Maschmeyer, Georg; Brink, Ingo; Brecht, Arne; Haberkorn, Uwe; Gaska, Tobias; Klapper, Wolfram; Hoelzer, Dieter; Jöckel, Karl-Heinz; Scherag, Andre; Bockisch, Andreas
    Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)
    In: Blood Jg. 124 (2014) Nr. 21, S. 391
    Online Volltext: dx.doi.org/
  • Bergmann, Anke K; Schneppenheim, Sina; Seifert, Marc; Betts, Matthew J; Haake, Andrea; Lopez, Cristina; Maria Murga Penas, Eva; Vater, Inga; Jayne, Sandrine; Dyer, Martin J S; Schrappe, Martin; Dührsen, Ulrich; Ammerpohl, Ole; Russell, Robert B; Küppers, Ralf; Dürig, Jan; Siebert, Reiner
    Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia
    In: Genes, Chromosomes and Cancer Jg. 53 (2014) Nr. 4, S. 309 - 316
    Online Volltext: dx.doi.org/
  • Sellner, Leopold; Dietrich, Sascha; Lukas, Marina; Ho, Anthony D.; Blume, Carolin; Stolz, Tatjana; Hensel, Manfred; Rossi, Davide; Zenz, Thorsten; Zirlik, Katja; Glimm, Hanno; Oles, Malgorzata; Huber, Wolfgang; Seiffert, Martina; Slabicki, Mikolaj; Sill, Martin; Kalle, Christof von; Jauch, Anna; Hüllein, Jennifer; Ringshausen, Ingo; Merkel, Olaf; Dreger, Peter; Herling, Marco; Dürig, Jan; Oakes, Christopher C.
    Systematic mapping of drug sensitivity in hematological malignancies identifies vulnerability of chronic lymphocytic leukemia with mutant p53
    In: Cancer Research Jg. 74 (2014) Nr. 19 Suppl., S. 5557
    Online Volltext: dx.doi.org/
  • Seckinger, A.; Meissner, T.; Bertsch, U.; Salwender, H.; Dürig, Jan; Hanel, M.; Blau, I.; Scheid, C.; Weisel, K.; Klein, B.; Goldschmidt, H.; Hose, D.
    Bone turnover in multiple myeloma : Impact of bortezomib-based induction therapy, high-dose melphalan, and lenalidomide consolidation on osteoblast and osteoclast function within the GMMG-MM5 trial
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 38 - 38
  • Fedorchenko, Oleg; Stiefelhagen, Marius; Peer-Zada, Abdul A; Barthel, Romy; Mayer, Petra; Eckei, Laura; Breuer, Alexandra; Crispatzu, Giuliano; Rosen, Natascha; Landwehr, Thomas; Lilienthal, Nils; Möllmann, Michael; Montesinos-Rongen, Manuel; Heukamp, Lukas; Dürig, Jan; Hallek, Michael; Fingerle-Rowson, Günter; Herling, Marco
    CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia
    In: Blood Jg. 121 (2013) Nr. 20, S. 4126 - 4136
    Online Volltext: dx.doi.org/
  • Dürig, Jan
    CLL associated immunodeficiency
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 1 - 1
  • Goethert, JoachimRud; Eisele, Lewin; Klein-Hitpaß, Ludger; Weber, Stefanie; Zesewitz, Marie-Loui; Sellmann, Ludger; Röth, Alexander; Pircher, Hanspeter; Dührsen, Ulrich; Dürig, Jan
    Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1(+) effector memory phenotype
    In: Cancer Immunology, Immunotherapy Jg. 62 (2013) Nr. 11, S. 1697 - 1709
    Online Volltext: dx.doi.org/
  • Hose, D.; Seckinger, A.; Meissner, T.; Bertsch, U.; Salwender, H.; Dürig, Jan; Hanel, M.; Blau, I.; Scheid, C.; Weisel, K.; Klein, B.; Goldschmidt, H.
    Gene expression profiling and its arrival in clinical routine
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 170 - 170
  • Dürig, Jan
    Indolent T-cell lymphomas (T-LGL and others)
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 87 - 87
  • Khandanpour, Cyrus; Dürig, Jan; Dührsen, Ulrich
    Leukämien : Modellkrankheiten für die Entstehung und Behandlung von Krebs
    In: Unikate: Berichte aus Forschung und Lehre (2013) Nr. 44: Medizin : 50 Jahre Universitätsklinikum Essen, S. 114 - 125
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Scholtysik, R.; Seifert, Marc; Jäger, Ursula; Tschurtschenthaler, G.; Dührsen, Ulrich; Küppers, Ralf; Dürig, Jan
    Next generation transcriptome sequencing confirms the presence of somatic STAT3 mutations and identifies novel TNFAIP3 mutations in T Large Granular Lymphocytic Leukemia (T-LGL)
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 196
  • Gobel, M.; Mollmann, M.; Gorgens, A.; Huttmann, A.; Dührsen, Ulrich; Giebel, Bernd; Unger, A.; Choidas, A.; Dürig, Jan
    Preclinical testing of a novel Axl-kinase inhibitor in Chronic Lymphocytic Leukemia
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 172 - 172
  • Eisele, Lewin; Dürig, Jan; Bröcker-Preuß, Martina; Dührsen, Ulrich; Bokhof, Beate; Erbel, Raimund; Moebus, Susanne; Jöckel, Karl-Heinz
    Prevalence and incidence of anemia in the German Heinz Nixdorf Recall Study
    In: Annals of Hematology Jg. 92 (2013) Nr. 6, S. 731 - 737
    Online Volltext: dx.doi.org/
  • Göbel, Maria; Eisele, Lewin; Möllmann, Michael; Hüttmann, Andreas; Johansson, Patricia; Scholtysik, Rene; Bergmann, Manuela; Busch, Raymonde; Döhner, Hartmut; Hallek, Michael; Seiler, Till; Stilgenbauer, Stephan; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia
    In: PLoS ONE Jg. 23 (2013) Nr. 8, S. e72107
    Online Volltext: dx.doi.org/ (Open Access)
  • Lutzny, Gloria; Kocher, Thomas; Schmidt-Supprian, Marc; Rudelius, Martina; Klein-Hitpaß, Ludger; Finch, Andrew J; Dürig, Jan; Wagner, Michaela; Haferlach, Claudia; Kohlmann, Alexander; Schnittger, Susanne; Seifert, Marc; Wanninger, Stefan; Zaborsky, Nadja; Oostendorp, Robert; Ruland, Jürgen; Leitges, Michael; Kuhnt, Toni; Schäfer, Yvonne; Lampl, Benedikt; Peschel, Christian; Egle, Alexander; Ringshausen, Ingo
    Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo
    In: Cancer Cell Jg. 23 (2013) Nr. 1, S. 77 - 92
    Online Volltext: dx.doi.org/ (Open Access)
  • Görgens, André; Radtke, Stefan; Möllmann, Michael; Cross, Michael; Dürig, Jan; Horn, Peter; Giebel, Bernd
    Revision of the Human Hematopoietic Tree: Granulocyte Subtypes Derive from Distinct Hematopoietic Lineages
    In: Cell Reports Jg. 3 (2013) Nr. 5, S. 1539 - 1552
    Online Volltext: dx.doi.org/
  • Rost, S.; Necke, M.; Weber, S.; Mollmann, M.; Gobel, M.; Opalka, Bertram; Dührsen, Ulrich; Dürig, Jan; Gothert, J. R.
    Abundance of a NOTCH1 mutated clone affects clinical outcome of patients with chronic lymphocytic leukemia
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 97 - 97
  • Oppliger Leibundgut, Elisabeth; Rogenmoser-Dissler, Daniela; de Beer, Dirk; Porret, Naomi A.; Zibellini, Silvia; Dürig, Jan; Röth, Alexander; Klingbiel, Dirk; Baerlocher, Gabriela M.
    CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasms
    In: Leukemia Research Jg. 36 (2012) Nr. 9, S. 1204 - 1207
    Online Volltext: dx.doi.org/
  • Seifert, Marc; Sellmann, Ludger; Bloehdorn, Johannes; Wein, Frederik; Stilgenbauer, Stephan; Dürig, Jan; Küppers, Ralf
    Cellular origin and pathophysiology of chronic lymphocytic leukemia
    In: Journal of Experimental Medicine (JEM) Jg. 209 (2012) Nr. 12, S. 2183 - 2198
    Online Volltext: dx.doi.org/ (Open Access)
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Scholtysik, René; Seifert, Marc; Jäger, Ulrich; Tschurtschenthaler, Gertraud; Dührsen, Ulrich; Küppers, Ralf; Dürig, Jan
    Combined SNP Microarray Based Genomic Mapping and Next Generation Transcriptome Sequencing Confirms the Presence of Somatic STAT3 Mutations and Identifies Novel Chromosomal Imbalances and Candidate Genes in T Large Granular Lymphocytic Leukemia (T-LGL)
    In: Blood Jg. 120 (2012) Nr. 21, S. 3512
    Online Volltext: dx.doi.org/
  • Hanoun, Maher; Eisele, Lewin; Suzuki, Masako; Greally, John M.; Hüttmann, Andreas; Aydin, Semra; Scholtysik, René; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia
    In: PLoS ONE Jg. 7 (2012) Nr. 12, S. e34347
    Online Volltext: dx.doi.org/ (Open Access)
  • Faure, C.; Eisele, Lewin; Bergmann, M.; Busch, R.; Stilgenbauer, S.; Dührsen, Ulrich; Dürig, Jan; Deutsch CLL Studiengrp DCLLSG
    Evaluation of free light-chain abnormalities as prognostic marker in Binet A stage chronic lymphocytic leukemia
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 99 - 99
  • Görgens, A.; Radtke, Stefan; Mollmann, M.; Dürig, Jan; Horn, Peter; Giebel, Bernd
    Functional analyses of human hemtopoietic CD133(+)CD34(+) and CD133(LOW/-)CD34(+) cells challenge the existence of human common myeloid progenitor cells
    In: Experimental Hematology Jg. 40 (2012) Nr. 8, Suppl. 1, S. 124
  • Görgens, Andre; Beckmann, Julia; Ludwig, Anna-Kristin; Möllmann, Michael; Dürig, Jan; Horn, Peter; Rajendran, Lawrence; Giebel, Bernd
    Lipid raft redistribution and morphological cell polarization are separable processes providing a basis for hematopoietic stem and progenitor cell migration
    In: The International Journal of Biochemistry & Cell Biology Jg. 44 (2012) Nr. 7, S. 1121 - 1132
    Online Volltext: dx.doi.org/
  • Goergens, Andre; Goebel, Maria; Mollmann, Michael; Ludwig, Anna-Kristin; Dührsen, Ulrich; Horn, Peter; Dürig, Jan; Giebel, Bernd
    Molecular and morphological cell polarizationis required for human hematopoietic stem and progenitor cell migration and homing
    In: Experimental Hematology Jg. 40 (2012) Nr. 8, Suppl. 1, S. S106 - S107
  • Goebel, Maria; Möllmann, Michael; Gorgens, A.; Dührsen, Ulrich; Huttmann, A.; Giebel, Bernd; Unger, A.; Choidas, A.; Dürig, Jan
    Preclinical Testing of a Novel Axl-Kinase Inhibitor in Chronic Lymphocytic Leukemia
    In: Blood Jg. 120 (2012) Nr. 21,
  • Eisele, Lewin; Dürig, Jan; Hüttmann, Andreas; Dührsen, Ulrich; Assert, Roland; Bokhof, B.; Erbel, Raimund; Mann, K.; Jöckel, Karl-Heinz; Moebus, Susanne; on behalf of the Heinz Nixdorf Recall Study Investigative Group
    Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany
    In: Annals of Hematology Jg. 91 (2012) Nr. 2, S. 243 - 248
    Online Volltext: dx.doi.org/
  • Gobel, M.; Eisele, Lewin; Hüttmann, Andreas; Bergmann, M.; Busch, R.; Stilgenbauer, S.; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan
    Progranulin plasma concentration is a novel independent prognostic marker in chronic lymphocytic leukemia
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 100
  • Lutzny, G.; Kocher, T.; Rudelius, M.; Schmidt-Supprian, M.; Klein-Hitpaß, Ludger; Dürig, Jan; Oostendorp, RAJ; Peschel, C.; Egle, A.; Ringshausen, I.
    Protein Kinase C-beta Dependent Activation of NF-kappa B in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B-Cells in Vivo
    In: Blood Jg. 120 (2012) Nr. 21, S. 314
  • Johansson, Patricia; Eisele, Lewin; Wymer, Leonie; Hollenbeck, Anita; Kahraman, Alisan; Hilgard, Gudrun; Dührsen, Ulrich; Bröcker-Preuß, Martina; Assert, Roland; Gerken, Guido; Schlaak, Jörg Friedrich; Roß, Rudolf Stefan; Dürig, Jan
    Serum immunoglobulin alterations in patients with chronic hepatitis C
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 142 - 143
  • Gobel, M.; Mollmann, M.; Gorgens, A.; Giebel, Bernd; Dührsen, Ulrich; Dürig, Jan
    Toll-like receptor 9 agonists induce polarization and migration of chronic lymphocytic leukemia cells
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 106
  • Weißhardt, Philipp; Trarbach, Tanja; Dürig, Jan; Paul, Andreas; Reis, Henning; Tilki, Derya; Miroschnik, Inna; Ergün, Süleyman; Klein, Diana
    Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab
    In: Histochemistry and Cell Biology Jg. 137 (2012) Nr. 3, S. 391 - 401
    Online Volltext: dx.doi.org/
  • Sellmann, Ludger; Carpinteiro, Alexander; Nückel, Holger; Scholtysik, René; Siemer, Dörte; Klein-Hipass, Ludger; Kube, Dieter; Dürig, Jan; Dührsen, Ulrich; Stanelle, Jens; Küppers, Ralf
    p53 protein expression in chronic lymphocytic leukemia
    In: Leukemia and Lymphoma Jg. 53 (2012) Nr. 7, S. 1282 - 1288
    Online Volltext: dx.doi.org/
  • Switala, M.; Nückel, Holger; Ochsenfarth, C.; Dürig, Jan; Dührsen, Ulrich; Horn, Peter; Rebmann, Vera
    Association of soluble MICA levels to the MICA-129 polymorphism and treatment free survival in chronic lymphocytic leukaemia patients
    In: Tissue Antigens Jg. 77 (2011) Nr. 5, S. 393 - 393
  • Wierda, William G.; Kipps, Thomas J.; Dürig, Jan; Griskevicius, Laimonas; Stilgenbauer, Stephan; Mayer, Jiří; Smolej, Lukáš; Hess, Georg; Griniute, Rasa; Hernandez-Ilizaliturri, Francisco J.; Padmanabhan, Swaminathan; Gorczyca, Michele; Chang, Chai-Ni; Chan, Geoffrey; Gupta, Ira; Nielsen, Tina G.; Russell, Charlotte A.; Chang, C.-N.
    Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia
    In: Blood Jg. 117 (2011) Nr. 24, S. 6450 - 6458
    Online Volltext: dx.doi.org/
  • Aydin, Semra; Grabellus, Florian; Eisele, Lewin; Möllmann, Michael; Hanoun, Maher; Ebeling, Peter; Moritz, Thomas; Nückel, Holger; Sak, Ali; Göthert, Joachim Rudolf; Dührsen, Ulrich; Dürig, Jan
    Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model
    In: European Journal of Haematology Jg. 87 (2011) Nr. 1, S. 10 - 19
    Online Volltext: dx.doi.org/
  • Eisele, Lewin; Dürig, Jan; Bokhof, B.; Huttmann, A.; Dührsen, Ulrich; Assert, Roland; Erbel, R.; Jockel, K. H.; Moebus, S.;
    Monoclonal gammopathy of undetermined significance and solid tumor development in the Heinz Nixdorf Recall Study
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 243
    Online Volltext: dx.doi.org/
  • May, T.; Schucht, R.; Zauers, J.; Dürig, Jan; Horn, Peter; Rebmann, Vera; Dührsen, Ulrich; Göthert, Joachim Rudolf; Opalka, Bertram;
    Novel human bone marrow stroma cell lines from a normal donor and leukemia and lymphoma patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 260
    Online Volltext: dx.doi.org/
  • Sellmann, Ludger; Röth, Alexander; Baerlocher, Gabriela M.; Küppers, Ralf; Siemer, Dörte; Seifert, Marc; Dürig, Jan; Dührsen, Ulrich; Nückel, Holger; Opalka, Bertram; Bartels, Marius; de Beer, Dirk
    Telomeres and prognosis in patients with chronic lymphocytic leukaemia
    In: International Journal of Hematology Jg. 93 (2011) Nr. 1, S. 74 - 82
    Online Volltext: dx.doi.org/
  • Dürig, Jan; Dührsen, Ulrich; Klein-Hitpaß, Ludger; Worm, J.; Rode Hansen, J.B.; Wissenbach, M.
    The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia
    In: Leukemia Jg. 25 (2011) Nr. 4, S. 638 - 647
    Online Volltext: dx.doi.org/
  • Johansson, Patricia; Maldonado de Dechene, E.; Eisele, Lewin; Kieruzel, Sabrina; Horn, Peter; Schmücker, U.; Vetter, Irina; Dührsen, Ulrich; Gerken, Guido; Dürig, Jan; Schlaak, Jörg Friedrich
    705 Increased prevalence of monoclonal b lymphocytosis in patients with chronic Hepatitis C
    In: Journal of Hepatology Jg. 52 (2010) Nr. Suppl. 1, S. S274
    Online Volltext: dx.doi.org/
  • Wierda, W. G.; Kipps, T. J.; Dürig, Jan; Griskevicius, L.; Stilgenbauer, S.; Mayer, J.; Gorczyca, M.; Andersen, M.; Nielsen, T.; Russell, C. A.
    Chemoimmunotherapy with ofatumumab, fludarabine, and cyclophosphamide (O-FC) in previously untreated patients with chronic lymphocytic leukemia (CLL)
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. Suppl. 15, S. 6520
    Online Volltext: dx.doi.org/
  • Handrick, René; Ontikatze, Teona; Bauer, Kerstin-Daniela; Freier, Florian; Rübel, Amelie; Dürig, Jan; Belka, Claus; Jendrossek, Verena
    Dihydroartemisinin induces apoptosis by a bak-dependent intrinsic pathway
    In: Molecular Cancer Therapeutics Jg. 9 (2010) Nr. 9, S. 2497 - 2510
    Online Volltext: dx.doi.org/ (Open Access)
  • Sellmann, Ludger; Scholtysik, Rene; Kreuz, Markus; Cyrull, Sandra; Tiacci, Enrico; Stanelle, Jens; Carpinteiro, Alexander; Nückel, Holger; Boes, Tanja; Gesk, Stefan; Siebert, Reiner; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan; Küppers, Ralf
    Gene dosage effects in chronic lymphocytic leukemia
    In: Cancer Genetics and Cytogenetics Jg. 203 (2010) Nr. 2, S. 149 - 160
    Online Volltext: dx.doi.org/
  • Wierda, William G.; Kipps, Thomas J.; Dürig, Jan; Griskevicius, Laimonas; Stilgenbauer, Stephan; Mayer, Jiri; Smolej, Lukas; Hess, Georg; Griniute, Rasa; Hernandez-Ilizaliturri, Francisco J.; Padmanabhan, Swaminathan; Gorczyca, Michele; Gupta, Ira; Nielsen, Tina G.; Russell, Charlotte A.
    Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukemia : Results From a Randomized, Multicenter, International, Two-Dose, Parallel-Group Phase II Trial
    In: Clinical Lymphoma, Myeloma & Leukemia Jg. 10 (2010) Nr. 3, S. E33 - E34
    Online Volltext: dx.doi.org/
  • Johansson, Patricia; Eisele, Lewin; Klein-Hitpaß, Ludger; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan; Nückel, Holger
    Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia
    In: Leukemia Research Jg. 34 (2010) Nr. 7, S. 892 - 898
    Online Volltext: dx.doi.org/
  • Eisele, Lewin; Dürig, Jan; Hüttmann, Andreas; Dührsen, U.; Führer, A.; Kieruzel, S.; Assert, Roland; Bokhof, B.; Erbel, Raimund; Mann, Klaus; Jöckel, Karl-Heinz; Moebus, Susanne;
    Prevalence of monoclonal gammopathy of undetermindes significance in a densley populated, highly industrialized area in Germany
    15th Congress of the European Hematology Association, Spain, Barcelona, June 10–13, 2010,
    In: Haematologica, the hematology journal Jg. 95 (2010) Nr. Suppl. 2, S. 394, 0949
  • Dührsen, Ulrich; Hüttmann, Andreas; Dürig, Jan
    Prognostic Significance of Molecular Remission in Follicular Lymphoma
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. 30, S. e613
    Online Volltext: dx.doi.org/
  • Aydin, S.; Grabellus, Florian; Ebeling, Peter; Mollmann, M.; Lewin, E.; Nükel, H.; Dürig, Jan
    The impact of CD38 in the CLL NOD/SCID xenograft model
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 200 - 201
  • Nückel, Holger; Switala, Magdalena; Sellmann, Ludger; Horn, Peter; Dürig, Jan; Dührsen, Ulrich; Küppers, Ralf; Grosse-Wilde, Hans; Rebmann, Vera
    The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia
    In: Leukemia Jg. 24 (2010) Nr. 6, S. 1152 - 1159
    Online Volltext: dx.doi.org/
  • Zenz, Thorsten; Benner, Axel; Dührsen, Ulrich; Dürig, Jan; Döhner, Hartmut; Siffert, Winfried; Stilgenbauer, Stephan; Nückel, Holger
    BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia
    In: Leukemia and Lymphoma Jg. 50 (2009) Nr. 11, S. 1837 - 1842
  • Wilde, Benjamin; Dolff, Sebastian; Cai, Xin; Specker, Christof; Becker, Jan; Tötsch, Martin; Costabel, Ulrich; Dürig, Jan; Kribben, Andreas; Tervaert, Jan Willem Cohen; Schmid, Kurt Werner; Witzke, Oliver
    CD4⁺CD25⁺ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis
    In: Nephrology Dialysis Transplantation (NDT) Jg. 24 (2009) Nr. 1, S. 161 - 171
    Online Volltext: dx.doi.org/ (Open Access)
  • Eisele, Lewin; Prinz, Robert; Klein-Hitpaß, Ludger; Nückel, Holger; Lowinksi, Kerstin; Thomale, Jürgen; Möller, Lars; Dührsen, Ulrich; Dürig, Jan
    Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia
    In: European Journal of Haematology Jg. 83 (2009) Nr. 4, S. 320 - 327
    Online Volltext: dx.doi.org/
  • Eisele, Lewin; Haddad, Tareq; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia
    In: Leukemia Research Jg. 33 (2009) Nr. 6, S. 775 - 778
    Online Volltext: dx.doi.org/
  • Nückel, Holger; Collins, Christa H.; Sellmann, Ludger; Dürig, Jan; Siffert, Winfried; Dührsen, Ulrich
    FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia
    In: European Journal of Haematology Jg. 83 (2009) Nr. 6, S. 541 - 549
    Online Volltext: dx.doi.org/
  • Bug, Stefanie; Dürig, Jan; Oyen, Florian; Klein-Hitpaß, Ludger; Martin-Subero, Jose; Harder, Lana; Baudis, Michael; Arnold, Norbert; Kordes, Uwe; Dührsen, Ulrich; Schneppenheim, Reinhard; Siebert, Reiner
    Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A–TCRAD juxtaposition
    In: Cancer Genetics and Cytogenetics Jg. 192 (2009) Nr. 1, S. 44 - 47
    Online Volltext: dx.doi.org/
  • Edelmann, J.; Klein-Hitpaß, Ludger; Führer, A.; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells
    In: Leukemia Research Jg. 32 (2008) Nr. 10, S. 1565 - 1572
    Online Volltext: dx.doi.org/
  • Dürig, Jan; Ebeling, Peter; Grabellus, Florian; Sorg, Ursula R.; Möllmann, Michael; Schütt, Philipp; Göthert, Joachim Rudolf; Sellmann, Ludger; Seeber, Siegfried; Flaßhove, Michael; Dührsen, Ulrich; Moritz, Thomas
    A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease
    In: Cancer Research Jg. 67 (2007) Nr. 18, S. 8653 - 8661
    Online Volltext: dx.doi.org/
  • Nückel, Holger; Frey, Ulrich; Bau, Maja; Sellmann, Ludger; Stanelle, Jens; Dürig, Jan; Jöckel, Karl-Heinz; Dührsen, Ulrich; Siffert, Winfried
    Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia
    In: Blood Jg. 109 (2007) Nr. 1, S. 290 - 297
    Online Volltext: dx.doi.org/
  • Dürig, Jan; Bug, S.; Klein-Hitpaß, Ludger; Boes, Tanja; Jöns, T.; Harder, L.; Baudis, M.; Dührsen, Ulrich; Siebert, Reiner
    Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)
    In: Leukemia Jg. 21 (2007) Nr. 10, S. 2153 - 2163
    Online Volltext: dx.doi.org/
  • Röth, Alexander; Dürig, Jan; Himmelreich, H.; Bug, S.; Siebert, Reiner; Dührsen, Ulrich; Lansdorp, M.; Baerlocher, Gabriele
    Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia
    In: Leukemia Jg. 21 (2007) Nr. 12, S. 2456 - 2462
    Online Volltext: dx.doi.org/
  • Sellmann, Ludger; Gesk, Stefan; Walter, Christoph; Ritgen, Matthias; Harder, Lana; Schroers, Roland; Siemer, Dörte; Nückel, Holger; Dührsen, Ulrich; Siebert, Reiner; Dürig, Jan; Küppers, Ralf
    Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia
    In: British Journal of Haematology Jg. 138 (2007) Nr. 2, S. 217 - 220
    Online Volltext: dx.doi.org/
  • Broemel, F.; Kruse, E.; Neuhäuser, Markus; Dürig, Jan; Jöckel, Karl-Heinz
    A correction for expression value dependencies in Affymetrix
    In: Online Journal of Bioinformatics (OJB) Jg. 7 (2006) Nr. 1, S. 1 - 14
    Online Volltext
  • Nückel, Holger; Frey, Ulrich; Sellmann, Ludger; Bau, M.; Dürig, Jan; Dührsen, Ulrich; Siffert, Winfried
    Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: lack of association with incidence, disease stage and progression-free survival
    In: Leukemia Jg. 20 (2006) Nr. 4, S. 724
    Online Volltext: dx.doi.org/
  • Hüttmann, Andreas; Klein-Hitpaß, Ludger; Thomale, Jürgen; Deenen, R.; Nückel, Holger; Ebeling, Peter; Führer, A.; Edelmann, J.; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status
    In: Leukemia Jg. 20 (2006) Nr. 10, S. 1774 - 1782
    Online Volltext: dx.doi.org/
  • Nückel, Holger; Hüttmann, Andreas; Klein-Hitpaß, Ludger; Schroers, Roland; Führer, Anja; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia
    In: Leukemia & Lymphoma Jg. 47 (2006) Nr. 6, S. 1053 - 1061
    Online Volltext: dx.doi.org/
  • Frey, Ulrich; Nückel, Holger; Sellmann, Ludger; Siemer, Dörte; Küppers, Ralf; Siemer, Dörte; Küppers, Ralf; Dürig, Jan; Dührsen, Ulrich; Siffert, Winfried
    The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia
    In: Clinical Cancer Research Jg. 12 (2006) Nr. 19, S. 5686 - 5692
    Online Volltext: dx.doi.org/
  • Schroers, R.; Griesinger, F.; Trümper, L.; Haase, D.; Kulle, B.; Klein-Hitpaß, Ludger; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan
    Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia
    In: Leukemia Jg. 19 (2005) Nr. 5, S. 750 - 758
    Online Volltext: dx.doi.org/
  • Nückel, Holger; Rebmann, Vera; Dürig, Jan; Dührsen, Ulrich; Grosse-Wilde, Hans
    HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia
    In: Blood Jg. 105 (2005) Nr. 4, S. 1694 - 1698
    Online Volltext: dx.doi.org/
  • Schroers, Roland; Pukrop, Tobias; Dürig, Jan; Haase, Detlef; Dührsen, Ulrich; Trümper, Lorenz; Griesinger, Frank
    B-cell chronic lymphocytic leukemia with aberrant CD8 expression : genetic and immunophenotypic analysis of prognostic factors
    In: Leukemia & Lymphoma Jg. 45 (2004) Nr. 8, S. 1677 - 1681
    Online Volltext: dx.doi.org/
  • Novotny, Jürgen; Rosenthal, C.; Dürig, Jan; Beelen, Dietrich
    Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation
    In: European Journal of Haematology Jg. 73 (2004) Nr. 1, S. 1 - 9
    Online Volltext: dx.doi.org/
  • Nückel, Holger; Frey, Ulrich; Dürig, Jan; Dührsen, Ulrich; Siffert, Winfried
    Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia
    In: Leukemia Jg. 18 (2004) Nr. 11, S. 1816 - 1823
    Online Volltext: dx.doi.org/
  • Deaglio, Silvia; Capobianco, Andrea; Bergui, Luciana; Dürig, Jan; Morabito, Fortunato; Dührsen, Ulrich; Malavasi, Fabio
    CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells
    In: Blood Jg. 102 (2003) Nr. 6, S. 2146 - 2155
    Online Volltext: dx.doi.org/
  • Dürig, Jan; Nückel, Holger; Hüttmann, Andreas; Kruse, Elisabeth; Hölter, Tanja; Halfmeyer, Katja; Führer, Anja; Rudolph, Roland; Kalhori, Nasa; Nusch, Arnd; Deaglio, Silvia; Malavasi, Fabio; Möröy, Tarik; Klein-Hitpaß, Ludger; Dührsen, Ulrich
    Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia
    In: Blood Jg. 101 (2003) Nr. 7, S. 2748 - 2755
    Online Volltext: dx.doi.org/
  • Nückel, Holger; Dürig, Jan; Dührsen, Ulrich
    Salvage chemotherapy according to the ASHAP protocol : a single-center study of 24 patients with relapsed or refractory aggressive non-Hodgkin's lymphomas
    In: Annals of Hematology Jg. 82 (2003) Nr. 8, S. 481 - 486
    Online Volltext: dx.doi.org/
  • Nückel, Holger; Frey, Ulrich; Dürig, Jan; Dührsen, Ulrich; Siffert, Winfried; Aral, Nese
    The CC genotype of the C825T polymorphism of the G protein beta3 gene (GNB3) is associated with a high relapse rate in patients with chronic lymphocytic leukaemia
    In: Leukemia & Lymphoma Jg. 44 (2003) Nr. 10, S. 1739 - 1743
    Online Volltext: dx.doi.org/
  • Dürig, Jan; Nückel, Holger; Cremer, M.; Führer, A.; Halfmeyer, K.; Fandrey, Joachim; Möröy, Tarik; Klein-Hitpaß, Ludger; Dührsen, Ulrich
    ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia
    In: Leukemia Jg. 17 (2003) Nr. 12, S. 2426 - 2434
    Online Volltext: dx.doi.org/
  • Dürig, Jan; Naschar, M.; Schmücker, U.; Renzing-Köhler, K.; Hölter, T.; Hüttmann, Andreas; Dührsen, Ulrich
    CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia
    In: Leukemia Jg. 16 (2002) Nr. 1, S. 30 - 35
    Online Volltext: dx.doi.org/
  • Dürig, Jan; Schmücker, U.; Dührsen, Ulrich
    Differential expression of chemokine receptors in B cell malignancies
    In: Leukemia Jg. 15 (2001) Nr. 5, S. 752 - 756
    Online Volltext
  • Dührsen, Ulrich; Martinez, Tanja; Vohwinkel, G.; Ergün, Süleyman; Sun, Li; Dürig, Jan; Hossfeld, Dieter Kurt; Fiedler, W.
    Effects of vascular endothelial and platelet-derived growth factor receptor inhibitors on long-term cultures from normal human bone marrow
    In: Growth Factors Jg. 19 (2001) Nr. 1, S. 1 - 17
    Online Volltext: dx.doi.org/
  • Dürig, Jan; Rosenthal, Christoph; Elmaagacli, Ahmet Hayri; Heyworth, C.; Halfmeyer, Katja; Kasper, C.; Novotny, Jürgen; Dührsen, Ulrich
    Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cells
    In: Leukemia Jg. 14 (2000) Nr. 9, S. 1652 - 1660
    Online Volltext
  • Dürig, Jan; Giese, Armin; Schulz-Schaeffer, Walter; Rosenthal, Christoph; Schmücker, Ute; Bieschke, Jan; Dührsen, Ulrich; Kretzschmar, Hans A.
    Differential constitutive and activation-dependent expression of prion protein in human peripheral blood leucocytes
    In: British Journal of Haematology Jg. 108 (2000) Nr. 3, S. 488 - 495
    Online Volltext: dx.doi.org/
  • Dürig, Jan; Rosenthal, Christoph; Halfmeyer, Katja; Wiemann, Martin; Novotny, Jürgen; Bingmann, Dieter; Dührsen, Ulrich; Schirrmacher, Karin
    Intercellular communication between bone marrow stromal cells and CD34+ haematopoietic progenitor cells is mediated by connexin 43-type gap junctions
    In: British Journal of Haematology Jg. 111 (2000) Nr. 2, S. 416 - 425
    Online Volltext: dx.doi.org/

    • Abstracts

  • Fürstenau, Moritz; Ritgen, Matthias; Robrecht, Sandra; Von Tresckow, Julia; Zhang, Can; Schilhabel, Anke; Gregor, Michael; Thornton, Patrick; Staber, Philipp Bernhard; Tadmor, Tamar; Lindström, Vesa; Juliusson, Gunnar; Janssens, Ann; Levin, Mark-David; Da Cunha-Bang, Caspar; Schneider, Christof; Goldschmidt, Neta; Vandenberghe, Elisabeth; Rossi, Davide; Benz, Rudolf A.; Heintel, Daniel; Poulsen, Christian Bjørn; Christiansen, Ilse; Frederiksen, Henrik; Enggaard, Lisbeth; Posthuma, Eduardus; Issa, Djamila; Visser, Hein; Bellido, Mar; Kutsch, Nadine; Dürig, Jan; Stehle, Alexander; Voehringer, Matthias C.; Böttcher, Sebastian; Schulte, Clemens; Simon, Florian; Fink, Anna-Maria; Fischer, Kirsten; Holmes, Emily; Kreuzer, Karl-Anton; Brüggemann, Monika; Tausch, Eugen; Stilgenbauer, Stephan; Hallek, Michael; Kater, Arnon P.; Niemann, Carsten Utoft; Eichhorst, Barbara F.
    First-Line Venetoclax Combinations in Fit Patients with CLL : 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial
    In: Blood Jg. 142 (2023) Nr. Supplement 1, S. 635 - 638
    Online Volltext: dx.doi.org/ (Open Access)
  • Denker, S.; Bittner, A.; Frick, M.; Kase, J.; Hoffmann, J.; Trenker, C.; Keller, U.; Bogner, C.; Hüttmann, Andreas; Dürig, Jan; Janz, M.; Mathas, S.; Marks, R.; Krohn, U.; Na, I.; Bhattacharya, A.; Hübner, N.; Akalin, A.; Bullinger, L.; Schmitt, C.A.
    Ibrutinib + bortezomib + R‐CHOP for higher‐risk DLBCL : Feasibility, efficacy and molecular predictors
    In: Hematological Oncology Jg. 41 (2023) Nr. S2, 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023, S. 424 - 425
    Online Volltext: dx.doi.org/ (Open Access)
  • Huber, H.; Tausch, E.; Schneider, C.; von Tresckow, Julia; Dürig, Jan; Stilgenbauer, S.; et al.;
    Treatment regimens in high-risk CLL
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment Jg. 46 (2023) Nr. Supplement 5: DGHO Abstracts, S. 19
    Online Volltext: dx.doi.org/ (Open Access)
  • Huber, Henriette; Tausch, Eugen; Schneider, Christof; Edenhofer, Simone; von Tresckow, Julia; Robrecht, Sandra; Giza, Adam; Zhang, Can; Furstenau, Moritz; Dreger, Peter; Ritgen, Matthias; Illmer, Thomas; Illert, Anna Lena; Dürig, Jan; Böttcher, Sebastian; Niemann, Carsten Utoft; Kneba, Michael; Fink, Anna-Maria; Fischer, Kirsten; Döhner, Hartmut; Hallek, Michael; Eichhorst, Barbara; Stilgenbauer, Stephan;
    Final Analysis of the Prospective Multicenter CLL2-Give Trial of Obinutuzumab (GA101, G), Ibrutinib (I), and Venetoclax (Ve) in Untreated Patients with CLL with 17p Deletion/TP53 Mutation
    64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans, LA, USA,
    In: Blood Jg. 140 (2022) Nr. Supplement 1, S. 834 - 836
    Online Volltext: dx.doi.org/ (Open Access)
  • Kersten, Marie José; Dreyling, Martin; Linton, Kim M.; Chitu, Dana; Tonino, Sanne; Kap, Marcel; Liu, Roberto D; Chamuleau, Martine E.D.; Visser, Hein P.J.; De Jongh, Eva; Marijt, Erik WAF; Leijs, Maria B.L.; Bilgin, Yavuz M.; Dürig, Jan; McKay, Pamela; Snijders, Tjeerd J.F.; Pettitt, Andrew; Minnema, Monique C.; Prange-Krex, Gabriele; Cuijpers, Maria; Böhmer, Lara H.; Tick, Lidwine W.; Florschütz, Axel; Silbermann, Matthijs; Fijnheer, Rob; Beeker, Aart; Tolboom, Nelleke; Mitea, Cristina; Arens, Anne IJ; Zwezerijnen, Gerben JC; Klapper, Wolfram; Coupland, Sarah E.; de Jong, Daphne; Doorduijn, Jeanette K.; Zijlstra, Josée M.;
    Lenalidomide-Rituximab or Lenalidomide-Rituximab-Bendamustine in Patients with Relapsed/Refractory Follicular Lymphoma : Priimary Analysis of the Randomized Phase II HOVON110/Rebel Trial
    64th Annual Meeting and Exposition of the American Society of Hematology ; December 10 - 13, 2022, New Orleans,
    In: Blood Jg. 140 (2022) Nr. Supplement 1: 64th Annual Meeting, S. 2283 - 2285
    Online Volltext: dx.doi.org/ (Open Access)
  • Goldschmidt, Hartmut; Mai, Elias K; Nievergall, Eva; Fenk, Roland; Bertsch, Uta; Tichy, Diana; Besemer, Britta; Dürig, Jan; Schroers, Roland; Metzler, Ivana v.; Haenel, Mathias; Mann, Christoph; Asemissen, Anne-Marie; Heilmeier, Bernhard; Huhn, Stefanie; Kriegsmann, Katharina; Weinhold, Niels; Luntz, Steffen P.; Holderried, Tobias A. W.; Trautmann-Grill, Karolin; Gezer, Deniz; Klaiber-Hakimi, Maika; Mueller, Martin; Khandanpour, Cyrus; Knauf, Wolfgang; Munder, Markus; Geer, Thomas; Riesenberg, Hendrik; Thomalla, Joerg; Hoffmann, Martin; Raab, Marc-Steffen; Salwender, Hans; Weisel, Katja;
    Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients : The Phase III GMMG-HD7 Trial
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 463 - 465
    Online Volltext: dx.doi.org/ (Open Access)
  • Goldschmidt, Hartmut; Mai, Elias K; Bertsch, Uta; Besemer, Britta; Haenel, Mathias; Miah, Kaya; Fenk, Roland; Schlenzka, Jana; Munder, Markus; Dürig, Jan; Blau, Igor Wolfgang; Huhn, Stefanie; Hose, Dirk; Jauch, Anna; Kunz, Christina; Neubauer, Andreas; Scheid, Christof; Schroers, Roland; Metzler, Ivana v.; Schieferdecker, Aneta; Thomalla, Joerg; Reimer, Peter; Mahlberg, Rolf; Graeven, Ullrich; Kremers, Stephan; Martens, Uwe M.; Kunz, Christian; Hensel, Manfred; Seidel-Glaetzer, Andrea; Weisel, Katja; Raab, Marc-Steffen; Salwender, Hans;
    Elotuzumab in Combination with Lenalidomide, Bortezomib, Dexamethasone and Autologous Transplantation for Newly-Diagnosed Multiple Myeloma : Results from the Randomized Phase III GMMG-HD6 Trial
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 486 - 488
    Online Volltext: dx.doi.org/ (Open Access)
  • Hoffmann, C.; Mohr, Christopher; Johansson, Patricia; Dürig, Jan; Schmeling, C.; Bechrakis, N.; Eckstein, Anja; Manthey, A.; Pöttgen, Christoph; Gauler, Thomas; Guberina, N.; Müller, Andrea; Stuschke, Martin; Guberina, M.
    Long-term Follow-Up in Patients with Stage IAE Orbital Lymphoma and Radiotherapy with Photons : Monocentric Results
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 58 - S59
  • Mai, Elias K; Hielscher, Thomas; Bertsch, Uta; Salwender, Hans; Zweegman, Sonja; Munder, Markus; Pantani, Lucia; Brossart, Peter; Beksac, Meral; Blau, Igor Wolfgang; Raab, Marc-Steffen; Dürig, Jan; Giesen, Nicola; Besemer, Britta; Fenk, Roland; Reimer, Peter; van der Holt, Bronno; Haenel, Mathias; Metzler, Ivana v.; Graeven, Ullrich; Boccadoro, Mario; Scheid, Christof; Dimopoulos, Meletios A.; Weisel, Katja; Cavo, Michele; Sonneveld, Pieter; Goldschmidt, Hartmut;
    Prediction of Early Death and Severe Infections during Novel Agent-Based Induction Therapy in Newly-Diagnosed Multiple Myeloma : An Intergroup Analysis from the German Speaking Myeloma Multicenter Group, the Dutch-Belgian Cooperative Trial Group for Hematology Oncology Foundation and the European Myeloma Network
    63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,
    In: Blood Jg. 138 (2021) Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 3792 - 3795
    Online Volltext: dx.doi.org/ (Open Access)
  • Mai, E. K.; Hielscher, T.; Bertsch, U.; Salwender, H. J.; Munder, M.; Brossart, P.; Blau, I. W.; Raab, M. S.; Dürig, Jan; Besemer, B.; Fenk, R.; Wattad, M.; Hänel, M.; Martin, H.; Graeven, U.; Scheid, Christoph; Weisel, K. C.; Goldschmidt, H.; German-speaking Myeloma Multicenter Group (GMMG);
    Severe infections and early death during novel agent-based induction therapy in newly-diagnosed, transplant-eligible multiple myeloma
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 21
    Online Volltext: dx.doi.org/ (Open Access)
  • Johansson, Patricia; Dierichs, L.; Klein-Hitpaß, Ludger; Bergmann, A.; Menninger, S.; Habenberger, P.; Klebl, B.; Siveke, Jens; Dührsen, U.; Choidas, A.; Dürig, Jan;
    Anti-leukemic activity through CDK9 inhibition in T-cell prolymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 218
    Online Volltext: dx.doi.org/ (Open Access)
  • Mai, Elias K.; Baertsch, Marc-A.; Hielscher, Thomas; Bertsch, Uta; Schlenzka, Jana; Salwender, Hans J.; Munder, Markus; Fuhrmann, Stephan; Dührsen, Ulrich; Brossart, Peter; Neben, Kai; Raab, Marc S.; Jauch, Anna; Seckinger, Anja; Hose, Dirk; Luntz, Steffen; Sonneveld, Pieter; Lokhorst, Henk; Martin, Hans; Lindemann, Hans-Walter; Blau, Igor Wolfgang; Scheid, Christof; Weisel, Katja; Haenel, Mathias; Dürig, Jan; Goldschmidt, Hartmut;
    Comparison of bortezomib versus lenalidomide maintenance therapy in newly-diagnosed, transplant-eligible multiple myeloma : Results from the phase III GMMG-HD4 and -MM5 trials
    17th International Myeloma Workshop ; September 12-15, 2019, Boston, MA, USA,
    In: Clinical Lymphoma, Myeloma & Leukemia Jg. 19 (2019) Nr. 10, Suppl., S. e43
    Online Volltext: dx.doi.org/
  • Dimopoulos, Meletios A.; Weisel, Katja; Moreau, Philippe; Anderson, Larry D.; White, Darrell; San-Miguel, Jesus; Sonneveld, Pieter; Engelhardt, Monika; Jenner, Matthew; Corso, Alessandro; Dürig, Jan; Pavic, Michel; Salomo, Morten; Casalz, Eva; Jiang, Ruiyun; Srinivasan, Shankar; Nguyen, Tuong Vi; Bensmaine, Amine; Peluso, Teresa; Richardson, Paul G.;
    Pomalidomide + Bortezomib + Dexamethasone After One Prior Line of Therapy in Bortezomib-Pretreated Multiple Myeloma : Subanalysis of OPTIMISMM
    17th International Myeloma Workshop ; September 12-15, 2019, Boston, MA, USA,
    In: Clinical Lymphoma, Myeloma & Leukemia Jg. 19 (2019) Nr. 10, Suppl., S. e32 - e33
    Online Volltext: dx.doi.org/
  • Dimopoulos, Meletios A.; Weisel, Katja C.; Moreau, Philippe; Anderson, Larry D.; White, Darrell J; San-Miguel, Jesús; Sonneveld, Pieter; Engelhardt, Monika; Jenner, Matthew; Corso, Alessandro; Dürig, Jan; Pavic, Michel; Salomo, Morten; Casal, Eva; Jiang, Ruiyun; Srinivasan, Shankar; Nguyen, Tuong Vi; Biyukov, Tsvetan; Peluso, Teresa; Richardson, Paul G.;
    Pomalidomide + Bortezomib + Low-Dose Dexamethasone after 1 Prior Line of Therapy in Patients with Lenalidomide-Pretreated Multiple Myeloma : Subanalysis of the Phase 3 Optimismm Trial By Patient Age and Prior Stem Cell Transplant
    61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Oralndo, USA,
    In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 3120 - 3120
    Online Volltext: dx.doi.org/ (Open Access)
  • Grząśko, Norbert; Knop, Stefan; Goldschmidt, Hartmut; Raab, Marc S; Dürig, Jan; Bringhen, Sara; D'Agostino, Mattia; Gamberi, Barbara; Rivolti, Elena; Vacca, Angelo; Ria, Roberto; Jurczyszyn, Artur; Castellano Acosta, Jorge; Lang, Doris; Lemaillet, Guy; Sudhir, Bansod; Szarejko, Monika;
    The MP0250-CP201 Mirror Study : A Phase 2 Study Update of MP0250 Plus Bortezomib and Dexamethasone in Relapse/Refractory Multiple Myeloma (RRMM) Patients Previously Exposed to Proteasome Inhibitors and Immunomodulatory Drugs
    61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Oralndo, USA,
    In: Blood Jg. 134 (2019) Nr. Supplement_1: Annual Meeting Abstracts, S. 1899 - 1899
    Online Volltext: dx.doi.org/ (Open Access)
  • Rummel, Mathias J; Lerchenmüller, Christian; Hensel, Manfred; Goerner, Martin; Buske, Christian; Schulz, Holger; Schmidt, Burkhard; Kojouharoff, Georgi; Lange, Elisabeth; Willenbacher, Wolfgang; Dürig, Jan; Engel, Erik; Kauff, Frank; Barth, Jürgen; Burchardt, Alexander Christoph; Hinke, Axel; Wupperfeld, Jasmin; Greil, Richard;
    Two Years Rituximab Maintenance Vs. Observation after First Line Treatment with Bendamustine Plus Rituximab (B-R) in Patients with Waldenström's Macroglobulinemia (MW) : Results of a Prospective, Randomized, Multicenter Phase 3 Study (the StiL NHL7-2008 MAINTAIN trial)
    61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,
    In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 343
    Online Volltext: dx.doi.org/ (Open Access)
  • Egle, A.; Jäger, U.; Skrabs, C.; Dürig, Jan; Nösslinger, T.; Wanner, D.; Steurer, M.; Ringshausen, I.; Melchardt, T.; Greil, R.; Ysebaert, L.;
    Unmaintained remission after discontinuation of kinase inhibitor treatment in chronic lymphocytic leukemia: an observational cohort
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,
    In: Oncology Research and Treatment Jg. 42 (2019) Nr. Supplement 4: Abstracts, S. 18
    Online Volltext: dx.doi.org/ (Open Access)
  • Schmidt, Christian; Zoellner, Anna-Katharina; Jurinovic, Vindi; Sökler, Martin; Forstpointner, Roswitha; Haubner, Sascha; Buske, Christian; Viardot, Andreas; Keller, Ulrich; Pott, Christiane; Graeven, Ullrich; Marks, Reinhard; Hänel, Mathias; Liersch, Ruediger; Dürig, Jan; Hoster, Eva; Unterhalt, Michael; Hiddemann, Wolfgang;
    Chemotherapy-Free Combination of Obinutuzumab and Ibrutinib in First LINE Treatment of Follicular Lymphoma : The Alternative Study By the German Low Grade Lymphoma Study Group (GLSG)
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood Jg. 132 (2018) Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 448 - 448
    Online Volltext: dx.doi.org/ (Open Access)
  • Rummel, M.; Buske, C.; Hertenstein, B.; Lerchenmüller, C. A.; Koenigsmann, M.; Lange, E.; Reeb, M.; Kaiser, U.; Balser, C.; Behringer, D.; Dürig, Jan; Gaska, T.; Maschmeyer, G.; Schliesser, G.; Burchardt, A.; Barth, J.; Kauff, F.; Hinke, A.; Greil, R.;
    Four versus two years of Rituximab maintenance (R-maintenance) following Bendamustine plus Rituximab (B-R): initial results of a prospective, randomized multicenter phase 3 study in first-line follicular lymphoma (the StiL NHL7-2008 MAINTAIN study)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 251
    Online Volltext: dx.doi.org/ (Open Access)
  • Keuneke, L.; Ossowski, J.; Becher, C.; Dürig, Jan; Johansson, Patricia; Bergmann, A. K.; Murga Penas, E. M.;
    Gain of STAT3/5 locus is a recurrent cryptic aberration in T-cell prolymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 318
    Online Volltext: dx.doi.org/ (Open Access)
  • Knop, Stefan; Goldschmidt, Hartmut; Raab, Marc S; Szarejko, Monika; Jurczyszyn, Artur; Dürig, Jan; Bringhen, Sara; Gamberi, Barbara; Vacca, Angelo; Castellano Acosta, Jorge; Lemaillet, Guy; Cortijo, Cedric; Sudhir, Bansod; Grząśko, Norbert;
    MP0250 Combined with Bortezomib and Dexamethasone in Multiple Myeloma Patients Previoulsy Exposed to Proteasome Inhibitors and Immunomodulatory Drugs
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood Jg. 132 (2018) Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 1980 - 1980
    Online Volltext: dx.doi.org/ (Open Access)
  • Dimopoulos, Meletios A; Weisel, Katja; Moreau, Philippe; Anderson, Larry; White, Darrell J; San-Miguel, Jesus F; Sonneveld, Pieter; Engelhardt, Monika; Jenner, Matthew W; Corso, Alessandro; Dürig, Jan; Pavic, Michel; Salomo, Morten; Yu, Xin; Nguyen, Tuong Vi; Bensmaine, Amine; Peluso, Teresa; Zaki, Mohamed; Richardson, Paul;
    Pomalidomide + Bortezomib + Low-Dose Dexamethasone Vs Bortezomib + Low-Dose Dexamethasone As Second-Line Treatment in Patients with Lenalidomide-Pretreated Multiple Myeloma : A Subgroup Analysis of the Phase 3 Optimismm Trial
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood Jg. 132 (2018) Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 3278 - 3278
    Online Volltext: dx.doi.org/ (Open Access)
  • Weisel, K.; Salwender, H.; Scheid, C.; Zago, M.; Besemer, B.; Hänel, M.; Dürig, Jan; Munder, M.; Lindemann, H.-W.; Seckinger, A.; Kunz, C.; Benner, A.; Hose, D.; Jauch, A.; Kanz, L.; Goldschmidt, H.; GMMG;
    Pomalidomide, cyclophosphamide and dexamethasone in case of suboptimal response to pomalidomide and dexamethasone alone in relapsed and/or refractory multiple myeloma : Final results of the GMMG-PERSPECTIVE trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 133 - 134
    Online Volltext: dx.doi.org/ (Open Access)
  • Dürig, Jan
    Preliminary data of the ongoing open-label, single-arm phase II study of MP0250 in combination with bortezomib plus dexamethasone in patients with relapsed refractory multiple myeloma
    In: Haematologica / The Hematology Journal Jg. 103 (2018) Nr. Suppl. 1,
  • Ossowski, J.; Keuneke, L.; Richter, J.; Dührsen, U.; Küppers, Ralf; Dürig, Jan; Johansson, Patricia; Murga Penas, E. M.; Bergmann, A. K.;
    The DNA-methylation status of BCL11B in T-Cell-Large Granular Lymphocytic Leukemia - a diagnostic target
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 317
    Online Volltext: dx.doi.org/ (Open Access)
  • Seckinger, Anja; Salwender, Hans Jürgen; Martin, Hans; Scheid, Christof; Hielscher, Thomas; Bertsch, Uta; Hummel, Manuela; Jauch, Anna; Knauf, Wolfgang; Emde, Martina; Beck, Susanne; Neben, Kai; Lokhorst, Henk M.; van der Holt, Bronno; Duehrsen, Ulrich; Dürig, Jan; Lindemann, Hans-Walter; Schmidt-Wolf, Ingo; Haenel, Mathias; Lathan, Bernd; Raab, Marc S; Müller-Tidow, Carsten; Sonneveld, Pieter; Blau, Igor Wolfgang; Hillengass, Jens; Weisel, Katja; Goldschmidt, Hartmut; Hose, Dirk;
    Treatment Response and Long-Term Survival in Multiple Myeloma in the GMMG-HD4 Trial - Neither Profit All Molecular Entities Alike, Nor Are Remissions to Different Regimen Equal
    60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,
    In: Blood Jg. 132 (2018) Nr. Supplement 1: 60th ASH Annual Meeting Abstracts, S. 4485 - 4485
    Online Volltext: dx.doi.org/ (Open Access)
  • Johansson, Patricia; Habenberger, Peter; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Küppers, Ralf; Schultz-Fademrecht, Carsten; Choidas, Axel; Dürig, Jan
    CDK9 Inhibition with LDC526 Is an Effective Treatment for T-Cell Prolymphocytic Leukemia (T-PLL) in Vitro
    In: Blood Jg. 130 (2017) Nr. Suppl. 1, S. 1262
    Online Volltext: dx.doi.org/
  • Johansson, Patricia; Pancaldi, V.; Castellano, G.; Oschlies, I.; Queiros, A.; Iaccarino, I.; Valencia, A.; Martin-Subero, J. I.; Penas, EMM; Ammerpohl, O.; Dührsen, Ulrich; Küppers, Ralf; Dürig, Jan; Siebert, R.; Pau, ECD; Bergmann, A. K.
    Epigenetic analyses of T-cell large granular lymphocytic leukemia identify differentially methylated enhancer regions leading to deregulation of gene interactions
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 109 - 110
    Online Volltext: dx.doi.org/
  • Dührsen, Ulrich; Hüttmann, Andreas; Muller, S.; Hertenstein, B.; Thomssen, H.; Kotzerke, J.; Mesters, R.; Berdel, W. E.; Franzius, C.; Kroschinsky, F.; Weckesser, M.; Kofahl-Krause, D.; Bengel, F. M.; Dürig, Jan; Matschke, Johannes; Pöppel, Thorsten; Ose, C.; Brinkmann, M.; La Rosee, P.; Freesmeyer, M.; Hertel, A.; Hoffkes, H. G.; Behringer, D.; Prange-Krex, G.; Wilop, S.; Krohn, T.; Holzinger, J.; Griesshammer, M.; Giagounidis, A.; Raghavachar, A.; Maschmeyer, G.; Brink, I.; Bernhard, H.; Haberkorn, U.; Gaska, T.; Kurch, L.; Klapper, W.; Hoelzer, D.; Geworski, L.; Jöckel, Karl-Heinz; Scherag, Andre; Rekowski, J.; Bockisch, Andreas; PETAL Trial Investigators
    Positron-emission tomography-guided therapy of aggressive non-Hodgkin lymphomas -final results of the PETAL trial
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, S. 202 - 203
    Online Volltext: dx.doi.org/
  • Johansson, Patricia; Klein-Hitpaß, Ludger; Bergmann, A.; Siebert, R.; Scholtysik, R.; Przekopowitz, M.; Seifert, M.; Zenz, T.; Dührsen, Ulrich; Küppers, Ralf; Dürig, Jan;
    Genomic profiling of T-cell Prolymphocytic Leukemia (T-PLL) identifies novel recurrent mutations in SAMHD1 and PTPRC
    Jahrestagung der ­Deutschen, Österreichischen und ­Schweizerischen ­Gesellschaften für Hämatologie und ­Medizinische Onkologie, Leipzig, 14.–18. Oktober 2016,
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 238 - 238
    Online Volltext: dx.doi.org/
  • Rost, S.; Mollmann, M.; Eisele, Lewin; Weber, S.; Opalka, Bertram; Dührsen, Ulrich; Dürig, Jan; Göthert, Joachim Rudolf;
    Establishment of a real-time PCR assay to quantify the size of a NOTCH1 mutated subclone in chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 60
    Online Volltext: dx.doi.org/
  • Zesewitz, M. L.; Eisele, Lewin; Weber, S.; Mollmann, M.; Rost, S.; Dührsen, Ulrich; Dürig, Jan; Göthert, Joachim Rudolf;
    Expansion of a stimulatory natural killer receptor NKp80-expessing CD8+T-cell subset in chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 191
    Online Volltext: dx.doi.org/
  • Johansson, Patricia; Nückel, Holger; Dührsen, Ulrich; Dürig, Jan;
    Percentage of smudge cells on routine blood smears predict time to first treatment and overall survival in patients with Binet stage A chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 139
    Online Volltext: dx.doi.org/
  • Imsak, R.; Göthert, Joachim Rudolf; Möllmann, M.; Dührsen, Ulrich; Eickhoff, J.; Baumann, M.; Unger, A.; Schulz-Fademrecht, C.; Dürig, Jan;
    Preclinical testing of a novel CDK9 inhibitor in chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 195 - 196
    Online Volltext: dx.doi.org/
  • Göbel, M.; Eisele, Lewin; Huttmann, A.; Klein-Hitpaß, Ludger; Dührsen, Ulrich; Dürig, Jan;
    Progranulin plasma levels predict time to first treatment and overall survival in chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 196 - 196
    Online Volltext: dx.doi.org/
  • Carpinteiro, Alexander; Keitsch, S.; Hessler, G.; Pozgajova, M.; Müller, Stefan; Dürig, Jan; Gulbins, Erich;
    Role of the acid sphingomyelinase in hematogenous tumor metastasis in a mouse model
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 46
    Online Volltext: dx.doi.org/
  • Kapp, Johanna; Ochsenfarth, Crista; Switala, Magdalena; Frey, Ulrich; Sellmann, Ludger; Dürig, Jan; Horn, Peter; Dührsen, Ulrich; Rebmann, Vera; Nuckel, Holger
    Association of HLA-G Haplotype Risk Model with Treatment Free Survival In Chronic Lymphocytic Leukemia Patients
    In: Blood Jg. 116 (2010) Nr. 21, S. 1002 - 1003
    Online Volltext: dx.doi.org/
  • Kapp, Johanna; Ochsenfarth, Crista; Switala, Magdalena; Frey, Ulrich; Sellmann, Ludger; Dürig, Jan; Horn, Peter; Dührsen, Ulrich; Rebmann, Vera; Nückel, Holger;
    Association of HLA-G haplotype risk model with treatment free survival in chronic lymphocytic leukemia patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, Berlin, Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 45
    Online Volltext: dx.doi.org/
  • Gigel, C.; Eisele, Lewin; Mollmann, M.; Klein-Hitpaß, Ludger; Koch, T.; Hansen, JBR; Orum, H.; Wissenbach, M.; Dührsen, Ulrich; Dürig, Jan;
    Comparing the pharmacological effects of the novel Locked Nucleic Acid (LNA) modified antisense Bcl-2 inhibitor SPC2996 and G3139 (oblimersen) in preclinical models of chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 184
    Online Volltext: dx.doi.org/
  • Gothert, J. R.; Eisele, Lewin; Klein-Hitpaß, Ludger; Weber, Stefanie; Fuhrer, A.; Sellmann, Ludger; Roth, A.; Pircher, H.; Duhrsen, U.; Dürig, Jan
    Expanded CD8(+) T-cells of murine and human B-CLL are driven into a senescent KLRG1(+) effector memory phenotype
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 201
    Online Volltext: dx.doi.org/
  • Gothert, Joachim Rudolf; Eisele, Lewin; Klein-Hitpaß, Ludger; Weber, Stefanie; Fuhrer, Anja; Sellmann, Ludger; Röth, Alexander; Dührsen, Ulrich; Pircher, Hanspeter; Dürig, Jan
    Expanded CLL CD8(+) T-Cells Are Driven Into a Senescent KLRG1(+) Effector Memory Phenotype
    In: Blood Jg. 116 (2010) Nr. 21, S. 403
  • Buttkereit, Ulrike; Mohamad, Sana; Lindemann, Monika; Göthert, Joachim Rudolf; Opalka, Bertram; Dürig, Jan; Dührsen, Ulrich
    Heterogeneous Interactions of Leukemic and Control Bone Marrow Stroma Cells with an AML Cell Line and AML Leukemic Blasts
    In: Blood Jg. 116 (2010) Nr. 21, S. 460
    Online Volltext: dx.doi.org/
  • Buttkereit, U.; Mohamad, Sana; Lindemann, Monika; Göthert, Joachim Rudolf; Opalka, Bertram; Dürig, Jan; Dührsen, Ulrich;
    Heterogeneous interactions of leukemic and control bone marrow stroma cells with an AML cell line and AML leukemic blasts
    Deutsche, Österreichische und Schweizerische Gesellschaften für Hämatologie und Onkologie Jahrestagung, Berlin, Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 235
    Online Volltext: dx.doi.org/
  • Nückel, Holger; Switala, Magdalena; Ochsenfarth, Crista; Dürig, Jan; Horn, Peter; Dührsen, Ulrich; Rebmann, Vera;
    High soluble MICA levels are associated to MICA-129 val/val genotypes and poor treatment free survival in chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 41 - 42
    Online Volltext: dx.doi.org/
  • Möllmann, M.; Eisele, Lewin; Göthert, Joachim Rudolf; Grabellus, Florian; Weber, S.; Dührsen, Ulrich; Dürig, Jan;
    Investigating the interaction of leukemic B and non-malignant T cells in a novel Rag2-/gamma c-/--xenograft model of human chronic lymphocytic leukemia (CLL)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 202
    Online Volltext: dx.doi.org/
  • Eisele, Lewin; Günther, F.; Ebeling, Peter; Nabring, J.; Dührsen, Ulrich; Dürig, Jan
    Outpatient management of acute myeloid leukemia after intensive consolidation chemotherapy is feasible and reduces hospital treatment costs
    In: Oncology Jg. 33 (2010) Nr. 12, S. 658 - 664
    Online Volltext: dx.doi.org/
  • Johansson, Patricia; Hollenbeck, Anita; Horn, Peter; Dührsen, Ulrich; Gerken, Guido; Dürig, Jan; Schlaak, Jörg Friedrich
    Polyclonal B-Cell activation and Expansion of Monoclonal B Cells in the Peripheral Blood of Patients with Chronic Hepatitis C
    In: Hepatology Jg. 52 (2010) Nr. Suppl. 1, S. 740A
    Online Volltext: dx.doi.org/
  • Johansson, Patricia; Hollenbeck, Anita; Klein-Hitpaß, Ludger; de Dechene, Maldonado E; Eisele, Lewin; Kieruzel, Sabrina; Horn, Peter; Schmücker, Ute; Vetter, Ina; Gerken, Guido; Dührsen, Ulrich; Dürig, Jan; Schlaak, Jörg Friedrich;
    Prevalence of B cell lymphoproliferative disorders in patients with chronic hepatitis C (CHC)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010, pp 109–206,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 157
    Online Volltext: dx.doi.org/
  • Eisele, Lewin; Dürig, Jan; Hüttmann, Andreas; Dührsen, Ulrich; Führer, Anja; Kieruzel, Sabrina; Assert, Roland; Bokhof, Beate; Erbel, Raimund; Mann, Klaus; Jöckel, Karl-Heinz; Moebus, Susanne
    Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Light-Chain MGUS (LCMGUS) In a Metropolitan Area In Germany
    In: Blood Jg. 116 (2010) Nr. 21, 4037
    Online Volltext: dx.doi.org/
  • Carpinteiro, Alexander; Keitsch, S.; Möllmann, M.; Dührsen, Ulrich; Dürig, Jan; Gulbins, Erich;
    Role of the antigenic stimulation in the pathogenesis of chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 39
    Online Volltext: dx.doi.org/
  • Dürig, Jan; Klein-Hitpaß, Ludger; Worm, J.; Hansen, JBR; Orum, H.; Dührsen, U.; Wissenbach, M.;
    The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 42
    Online Volltext: dx.doi.org/

    • Beiträge in Sammelwerken und Tagungsbänden

  • Dürig, Jan
    Large Granular Lymphocyte Leukemia
    In: Chronic Lymphocytic Leukemia / Hallek, Michael; Eichhorst, Barbara; Catovsky, Daniel (Hrsg.) 2019, S. 167 - 179
    Online Volltext: dx.doi.org/ Online Volltext (Open Access)

    • Poster / Posterbeiträge

  • Mai, Elias; Hielscher, Thomas; Bertsch, Uta; Salwender, Hans J.; Munder, Markus; Brossart, Peter; Blau, Igor W.; Raab, Marc; Dürig, Jan; Giesen, Nicola; Besemer, Britta; Fenk, Roland; Wattad, Mohammed; Haenel, Mathias; von Metzler, Ivana; Graeven, Ullrich; Scheid, Christoph; Weisel, Katja; Goldschmidt, Hartmut;
    Predictive factors for severe infections and early death during novel agent-based induction therapy in newly diagnosed, transplant-eligible myeloma : a multicohort analysis from phase III trials
    18th International Myeloma Workshop ; September 8 - 11, 2021, Vienna, Austria,
    In: Clinical Lymphoma, Myeloma & Leukemia Jg. 21 (2021) Nr. Suppl. 2, S. S133 - S134
    Online Volltext: dx.doi.org/